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Hemocompatibility Assessment of 3C-SiC for Cardiovascular Applications
Norelli Schettini
ABSTRACT
The hemocompatibility of crystalline Silicon Carbide (SiC), in its cubic form (i.e.,
3C-SiC), has been evaluated and compared to Silicon (Si), the leading material in
biosensing applications. Silicon carbide (SiC) is a hard, chemically robust material, very
well suited for harsh environment applications, and has been suggested to have very good
biocompatibility. Additionally, SiC in its amorphous form, has been used as a coating for
medical implantable devices such as bone prosthetics and cardiovascular stents.
However, assessment of single crystal 3C-SiC for cardiovascular applications has not
been reported. In this research we have studied the interactions of single crystal 3C-SiC
with platelets and human microvascular endothelial cell (HMVEC) to assess the degree
of hemocompatibility of 3C-SiC.
The more hemocompatible a material is, the less platelet adhesion would be
expected. Using fluorescence microscopy higher platelet adhesion was statistically
observed on Si than on SiC. In addition 3C-SiC surfaces showed less platelet reactivity,
measured by the degree of platelet adhesion, aggregation and activation, with mostly
circular morphology of adhered platelets while Si showed an elevated presence of nonactivated (Circular) platelet clumps.

vii

Additionally, HMVEC proliferation assessment suggest that 3C-SiC performs
comparably to high attachment culture wells with enhanced proliferation, without
affecting cell morphology.
These results suggest that 3C-SiC is a promising candidate for applications in the
blood stream due to its low thrombogenic characteristics and good hemocompatibility.

viii

Chapter. 1:

Introduction

Biocompatibility is the required property of materials and systems that are intended to
be in contact with biological matter to perform according to the system design but
without interfering with the integrity of the tissues and biological matter that such
material is in contact with and without generating any adverse reactions [1].
Silicon (Si) has been long used in the construction of Microelectromechanical
systems, MEMS, devices. Subsequently; the question of whether silicon is or is not a
biocompatible/suitable material for biotechnology applications or implantable devices is
a crucial question in the area of microfabrication and biomedical sensing devices.
Although this question seems a simple one, and the kind that one should be able to solve
with some literature search, this search usually tends to provide answers as complex as
the biological systems that we try to work with.
First, one cannot talk about a biocompatible material in an absolute way, as a material
that performs extraordinarily well for some biological matter can be devastating for
others and additionally there is a lot of uncertainty about the mechanisms that determine
biocompatibility as there as many ways in which tissues and materials interact [2]. In the
case of silicon previous research shows that the material can perform well for certain
tissues but can be cytotoxic for others [1] [3] [4]. Many limitations have been reported
for devices fabricated with Si, including carcinogenic effects due to the presence of
minute silicate particulates, inflammatory responses and device encapsulation.
The limitations of how compatible a material is when in contact with tissues is limited
by the application, e.g., issue engineering, implantable sensors, drug delivery, etc. If the
1

application to be developed requires the proliferation of cells on the surface of a device,
such as grafts, cell viability can be considered a pretty good measurement of a material's
biocompatibility, but if the material is going to be in contact with blood then we need
measurements of the degree of thrombogenicity, defined as the tendency of a material in
contact with blood to produce or induce thrombus formation [1] [5].
Biocompatibility is also defined in terms of behaviors that are desirable for a material
in contact with biological matter, e.g., a material being non-toxic, non-immunogenic, non
carcinogenic, non irritant and so on. Another factor of supreme importance is the implant
life time. In the case of short term implants advanced biopolymers offer excellent
biocompatible surfaces, but this solution is not suitable for long term implants as these
biopolymers tend to degrade in the harsh environment of the human body. In addition,
polymers also lack the sensing capabilities that semiconductor materials have, this is
especially important in the case on bio-sensing implantable devices.
The particular case of material biocompatibility with blood (and the cardiovascular
system in general) is called hemocompatibility and this research explores different
aspects of the biocompatibility of single crystal 3C-SiC as a potential material for future
cardiovascular applications due to its less bioreactive nature when in contact with
biological samples and its high degree of proven chemical resilience.

1.1

Research Objective and Motivation
Heart failure and stroke are two of the leading causes of death in the United States

every year. Today, patients with cardiovascular conditions can benefit from new
medications, improved means of cardiovascular monitoring and treatments which were
unavailable in the past; however there is still room for improved cardiovascular
2

therapeutic devices based on biotechnology, ranging from real-time detection and
monitoring of cardiac event markers to accurately timed drug delivery and dosage.
Unfortunately, current technology does not allow for their realization due to the
insufficient performance of the present biomaterials. Clearly, there is a critical need for a
new class of biomaterials that are hemocompatible and that could also allow the
fabrication of MEMS-based sensing devices.
Developing a sensor that operates in real-time and in vivo represents a challenge
dominated by the hemocompatibility of the materials used and the successful
accomplishment of different requirements such as matching blood flow dynamics,
duration of blood contact, selection of an appropriate sensor geometry, and sensor surface
quality (in terms of surface roughness) and chemistry (i.e., specific adhesion of the target
molecule). The formerly mentioned requirements are necessary to avoid device-induced
thrombus formation which can be life threatening either because of device failure or
because of thrombi embolization [6] [7].
Silicon carbide (SiC) is a hard, chemically robust material, very well suited for harsh
environment applications such as implantable devices in the human body [8] [9]. Recent
assessment of the single crystal form of this material (by Dr. C. Coletti and Dr. C. Frewin
in the SiC and Drug and Gene Delivery laboratories at USF), suggests that it has very
good biocompatibility [9] [10] [11]. Moreover, SiC, in its amorphous form, has been used
previously as a coating for medical implantable devices such as bone prosthetics and
cardiovascular stents [8] [12]. However, assessment of single crystal SiC for
cardiovascular applications has not been reported and is the focus of this dissertation
research.
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Single crystalline SiC grows in many crystal forms, but only one form of SiC is both
cubic and can be grown on single crystal Si substrates – 3C-SiC. Single crystal 3C-SiC
is highly resistant to harsh environments and it is chemically inert. It can be grown
heteroepitaxially on silicon substrates and standard silicon processing can be used to
micro-machine this material [13]. However, in order to exploit these material properties
for a blood-stream implantable device, its biocompatibility with blood and vascular
endothelial lining must be assessed.
This research looks for establishing whether or not single crystal 3C-SiC is a
hemocompatible material suitable for cardiovascular applications, through the
explorations of its platelet adhesion and biocompatibility with human microvascular
endothelial cells.
Next, an introduction to thrombus formation, biocompatibility testing and the
biocompatibility of 3C-SiC is presented to further understand the processes behind
thrombogenicity and the rationale behind the different aspects that we have chosen to
evaluate to determine the degree of hemocompatibility of 3C-SiC.

1.1.1

Thrombus Formation

Device hemo-in-compatibility occurs when a blood-contacting man-made device
induces thrombus formation [6]. Almost immediately after injury or the introduction of a
foreign material into the body clotting factors become activated (see figure 1. Top) and
induce the generation of an enzyme called thrombin [14]. Thrombin converts the soluble
protein fibrinogen into insoluble fibrin. The formed fibrin provides the scaffold for the
entrapment of platelets, blood cells, and plasma proteins (indeed this is critical for patient
survival as it is the mechanism behind blood clotting).
4

In the case of a blood-contacting device, key blood proteins, such as fibrinogen and
von Willebrand’s factor, that can trigger the clotting cascade (Figure 1. Top), adsorb onto
the surface of the device (Figure 1. Bottom), This is followed by the adhesion of platelets
to these proteins on the surface of the implanted probe, through key receptors on the
surface of platelets that bind fibrinogen and von Willebrand’s factor, as well as platelet
activation; such binding to surface-adsorbed proteins plays an important role in the
clotting cascade [15] [16] [17].

Figure 1.1. (Top) Flow diagram of the clotting cascade showing both, extrinsic and
intrinsic pathways [6]. (Bottom) Sequence of events that leads to thrombus formation on
the surface of a man-made material placed within the blood stream [16].
5

The platelet’s main function is to seal openings in the vascular tree. It is necessary,
subsequently, that the initiation signal for platelet deposition and activation is exposure of
the underlying vessel wall, that are normally hidden from circulating platelets by a noncompromised endothelial lining [15].
Additional parameters determining platelet response are the depth of the injury, the
vascular bed, age of the individual, hematocrit value (blood volume occupied by red
cells), the speed of blood flow and the size of the blood vessel [15].
For platelet plug formation to occur, platelets must undergo adhesion, activation and
aggregation [18] [19]. Most platelet activators are released or synthesized at the place of
the vascular injury. Additionally, biochemical interactions between platelets and
erythrocytes (red cells) also enhance platelet activation. Adhesion of platelets to
subendothelial structures may lead itself to platelet activation [6] [15].
Once activated, platelets suffer a change in their discoid shape which occurs in
response to many different agents, resulting in a transformation to a spiny sphere with
long, thin filopodia extending several micrometers out from the membrane surface [15].
When platelets adhere to surfaces, they generally undergo spreading and activation
which depends on the protein surface on which they spread to, with collagen inducing the
most activation. Platelet spreading results in the development of broad lamellipodia rather
than spike-like filopodia (see Figure 2) which is accompanied by granule secretion [15].
Intravascular placement is the most desirable for most chemical measurement.
However, platelet role in the vascular tree healing process, as well as the processes that
intervene in platelet adhesion, spreading, aggregation and activation, all must be
considered when studying the issue of device implantation. In addition there is the role
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played by platelet activators and glycoprotein ligands, platelets changes and surface
proteomics. These are complicated bio-physical processes that must be well understood
before considering the placement of a man-made sensor or material into the
cardiovascular system. The biological response of the body to foreign materials
determines the success of implantable biosensors and the degree of their
bio/hemocompatibility.
Once the blood clot is formed, the clot itself promotes more clotting; the platelet
thrombi appear capable of rapidly recruiting tissue factor (thromboplastin) from the blood
which is associated with P-selectin glycoprotein ligand (PSGL-1), a ligand for the Pselecting expressed on the surface of activated platelets. Activated platelets also recruit
neutrophils and monocytes expressing PSGL-1 [15].

Figure 1.2. Platelet lamellipodia and filopodia after activation on a surface.
Adapted from [6]

Activation of the clotting cascade by intravascular sensors presents risks to the patient
in that emboli may be shed and clog blood vessels elsewhere in the body [6]. Therefore,
careful selection of suitable hemocompatible material is the first step that must be
undertaken before developing any sensor for the cardiovascular system.

7

From the sensor device data-collection perspective, the presence of activated platelets
on the surface of an implanted chemical sensor can create a local chemical environment
that differs from that of bulk blood. Even in the absence of complete thrombus formation
on the surface of the device, a monolayer of active cells can cause significant
measurement errors; hence, the activity of cells adhered to the surface of any implanted
sensor can act like an immobilized enzyme catalyst to create a similar local change in key
analyte levels [16].

The former implies the need for a material for sensor device

fabrication that not only reduces thrombus formation (or eliminates it in the best case
scenario); by controlling protein activity on the surface of the device, but also that
minimizes platelet adhesion.
The use of an immobilized heparin coating on the surface of the implanted device,
which is the current strategy used by most researchers [20], is not a solution either,
because such coatings have been shown to not reduce platelet activation and adhesion on
foreign materials. Heparin coatings as an anticoagulant does reduce the size of the
thrombus formed on the device by locally inhibiting the activities of thrombin and Factor
Xa, however it will not significantly diminish the presence of adhered, metabolically
active cells [16] and, moreover, it will be consumed over time, so it is clearly not a good
option for long-term implantable devices.
Implantable sensors are subject to an acute inflammatory response that involves the
release of fluid and plasma proteins followed by recruitment of leukocytes to the implant
site.

8

Figure 1.3. Sequence of events that leads to formation of fibrous capsules around
sensors [16].

Leukocytes (mainly neutrophils and monocytes) migrate to the implanted device and
adhere to the surface in an attempt to begin the process of phagocytosis. Finally, a fibrous
capsule composed mainly of macrophages and collagen forms around the implanted
device. The capsule can alter local analyte levels via metabolic reactions [16].
Different approaches can be used to determine and modify the degree of
thrombogenicity of MEMS materials, including biomolecular surface interactions. For
vascular implants, human microvascular endothelial cells and platelets must be used to
assess the hemocompatibility of any foreign material inserted into the vascular system.
Endothelial cells relate directly to platelet interactions and bio/hemocompatibility of
materials; the inner lining of the endothelium constitutes the blood’s natural compatible
surface and does not promote platelet attachment. The interactions of both endothelial
cells and platelets with a desirable material for device implantation must be studied to get
a full insight on the material’s biocompatibility, as well as the blood protein interactions
with these foreign surfaces [21].

9

1.2

SiC Properties
SiC is a wide-bandgap (great sensing potential), optically transparent semiconducting

material that exhibits great electrical properties in harsh environments, such as high
temperature elasticity and chemical inertness [22].
Table I displays some of the various properties of silicon carbide. Its electrical,
mechanical and chemical properties (i.e., resistance to corrosion and wear, etc.) make it
an ideal candidate for sensing applications, such as MEMS devices.

Table 1.1. Electrical, thermal and physical properties of SiC and Si [18]
3C-SiC
4H-SiC
6H-SiC
Si
Bandgap (eV)
2.36
3.23
3.0
1.12
Breakdown field (MV cm-1)
1
3-5
3-5
0.25
2 -1 -1
Electron Mobility (cm V s )
<800
<900
<400
1500
at 300K
Hole Mobility
(cm2 V-1s-1)
<320
<120
<90
450
at 300K
Thermal conductivity
5
4.9
4.9
1.5
(W/cm-K)
4.3 ┴ c
Thermal expansion @300 K
3.8
2.6
axis
NA
4.7 ║ c
@1500-1600 K (10-6 K-1)
5.5
4.56-4.6
axis
Young’s Modulus (GPa)
300 to 700
47

SiC forms in three main crystal orientations; cubic (3C-SiC), hexagonal (4H-SiC and
6H-SiC), and rhombohedral (15R-SiC) where 4H-, 6H-, and 3C-SiC are the main
polytypes of practical and commercial interest [22]. As SiC is not a chemical compound
normally found in nature it must be artificially generated. One of the methods used for
the creation of single crystal, high quality SiC material is provided through the use of a
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chemical vapor deposition (CVD) on a bulk crystal which is performed at high
temperatures [23].
3C-SiC is the only single crystal form of SiC that can be grown heteroepitaxially
using Si as a substrate, due to the similarities in the crystal lattice structures (i.e., crystal
lattice). In addition 3C-SiC is already a well established semiconductor and MEMS
material [22] [24]. 3C-SiC also has the benefit of being compatible with most Si
micromachining techniques, such as reactive ion etching (RIE) and ion implantation [24]
[25].
To date, few crystalline semiconductor materials have been assessed for their
biocompatibility. Si, the leading material in the MEMS field, has been shown to be
cytotoxic, due to the formation of silica and silicates in aqueous solutions [3] [26] [27]
[28] [29]. Other materials, which do not undergo hemo-in-compatibility problems, but
that are not suitable for sensing applications, have been used as coatings for short-term
contact applications.
Materials such as polymers are consumed over time when implanted in the body, so
they do not offer an alternative for long-term implantable applications even though they
are the most developed material for this application. One advantage of such materials is
their very low cost, which is important for short-time, high-volume (device quantity)
implantable applications.
There is evidently a need for a crystalline material with suitable characteristics for
sensing applications in harsh environments, such as in bodily fluids, which also provides
a bio/hemocompatible surface.

11

SiC, in its amorphous form, has been used successfully as a coating for prosthetic
devices, it is one of the most used materials for cardiovascular applications, and has been
shown to be highly effective in vivo clinical trials as a coating for heart stents [8] [12]
[21] [26] [30] [31] [32] [33]. The literature also reveals that collagen deposition on SiC
whiskers is non progressive and that it generates an inflammatory response that decreases
gradually after implantation [32]
All of the above suggest attractive bio/hemocompatibility properties of this material
in its amorphous form and one could suspect that 3C-SiC, in its single crystal form,
should evidence the same properties; however, before the research conducted by Dr. C.
Coletti of the SiC group at the University of South Florida, no previous research on the
biocompatibility of single crystal 3C-SiC had been reported in the literature [9] [10] [34].

1.2.1

SiC a Promising Material for Biosensing Applications in the Blood Stream

SiC is a polymorphic material, having approximately 170 different crystal
organizations, but sharing a common stoichiometry (i.e., all forms contain bi-layers of Si
and C) [22]. Two of the hexagonal polytypes, 4H-SiC and 6H-SiC, have been fashioned
in the past into electrode myocardial sensors and have shown low biofouling, nontoxicity and in general good biocompatibility [35] [36]. Amorphous and polycrystalline
forms of silicon carbide, a-SiC and poly-SiC, have been used as coatings for many
implantable biomedical devices, and clinical studies for bone prosthetics and heart stents
have confirmed its biocompatibility.
Dr. C. Coletti researched the in vitro biocompatibility of three lines of cells, namely
B16-F10 mouse melanoma cells (ATCC CRL6475), BJ human fibroblasts (ATCC
CRL2522) and human keratinocytes (HaCaT) by plating and culturing them in the
12

appropriate media onto the surfaces of the main polytypes of SiC: 3C-SiC, 4H-SiC, and
6H-SiC, and assessing cell morphology, attachment to the substrate surface, successful
cellular binding and proliferation [9].
In her research, Coletti used Si and standard culture plates, as negative and positive
controls respectively, which served as benchmarks for biocompatibility comparisons [9].
These three different cells lines were selected for their different adhesion properties, i.e.,
B16 melanoma cells are very aggressive, proliferate at a fast rate and adhere indifferently
on substrates with different degrees of biocompatibility, conversely, BJ fibroblasts are
much more selective as to a preferred substrate for adherence and should provide more
information regarding a substrate’s degree of biocompatibility [9].

Figure 1.4. Fluorescent micrographs of (a) B16 melanoma cells (b) BJ fibroblast cells and
(c) HaCaT keratinocyte cells on SiC substrates 72 hours after seeding [9].

Figure 1.5. Fluorescent micrographs of (a) B16 melanoma cells (b) BJ fibroblast cells
and (c) HaCaT keratinocyte cells on Si substrates 72 hours after seeding [9].
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Figure 1.6. Histogram of cell proliferation of B16, BJ and HaCaT cells, normalized to the
control sample, expressed as x ± σ measured via MTT assays at the third day. Note that
cell proliferation is greater on SiC than on Si [9].

In Coletti’s study, the viability and proliferation of the cultured cells was assessed
using separate MTT [3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide]
assays for the three different cell lines. The adherent cell morphology was studied using
fluorescence microscopy. SiC samples, Si samples, and cell-culture wells were plated and
the cell morphology was inspected after 4, 24, 48, 72 hours for the B16 cells and 4, 24,
48, 72, 96 and 120 for the BJ and HaCaT cells. The cells were fluorescently labeled with
CMFDA (5- chloromethylfluorescein diacetate) cell tracker dye (Molecular Probes,
Eugene, OR) [9].
Optical inspection revealed that both the B16 and BJ cells were well distributed on
the SiC surfaces after 4 hours of incubation, elongated and flattened against the surface
after 24 hours, and became confluent after 3 days (B16) and 5 days (BJ and HaCaT)
independently of polytype used, and chemical composition [9]. Images of B16, BJ and
HaCaT cells cultured on SiC (72 hours after seeding), where the adherent cells appear to
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be flattened and stellate-shaped, maximizing the contact area with the substrate and
similar to that observed in culture wells, are shown in Figure 4 (a, b and c). The lack of
SiC cytotoxicity was confirmed by the fact that the cells could be cultured to confluence
on all the SiC substrates used [9].
The morphology and density of B16, BJ and HaCaT cells cultured on Si substrates
under identical conditions revealed that B16 cells tended to form in clumps, while the
adherent cell quantity, in the case of BJ fibroblasts and HaCaT keratinocytes, was
drastically reduced (see Figure 5). In addition, the reduced contact area of the adherent
cells (low adhesion force) suggests some degree of cytotoxicity for the Si substrates [9].
Figure 6 shows a histogram of the calculated cell viability from MTT assays,
performed on the third day for the three different cell lines, which confirmed the optical
inspection results. The histogram clearly shows that SiC is a high-quality surface for cell
culture with significantly better performance than Si. No statistically significant
differences in cell proliferation were found among the different SiC polytypes [9].
An extremely satisfying proliferation was observed for BJ cells on SiC [9]. From the
histogram it is also clear that the B16 cell proliferation is lower than the BJ cell
proliferation on SiC substrates but always higher than on Si.
As in this study the variation of roughness of the different substrates was very small
compared to the cell dimensions. Therefore future work regarding surface roughness
effects on the biocompatibility must be performed, with roughness values exceeding the
cell diameter. Surface roughness also plays a role in hemocompatibility, as high surface
roughness can lead to blood cells lysis and induce clotting.
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After the results of Dr. Coletti the biocompatibility of 3C-SiC seemed promising.
Subsequently, Dr. Frewin, also in the USF SiC group, engaged in the research of the
neuron-SiC interface and the development of Brain Machine Interface (BMI) devices. In
his research Dr. Frewin proposed cubic silicon carbide (3C-SiC) as a solution to the
biocompatibility problems of current implantable BMI devices. Dr. Frewin's study [11]
showed that both materials possess good biocompatibility with neural cell lines (human
neuroglioma and PC12 rat pheochromocytoma cell lines) that, in the worst case, is
comparable to cell treated polystyrene and, in most cases, even surpasses polystyrene.
Additionally, in this research the action potential of differentiated PC12 cells was
activated using 3C-SiC within an electrode device.
H4 human neuroglioma and PC12 rat pheochromocytoma cell lines were used for the
study, and polystyrene (PSt) and amorphous glass were used as controls or for
morphological comparison. MTT assays were performed to determine general cell
viability with each substrate and atomic force microscopy (AFM) was used to quantify
the general cell morphology on the substrate surface along with the substrate
permissiveness to lamellipodia extension. 3C-SiC was the only substrate tested to have
good viability and superior lamellipodia permissiveness with both cell lines, while nanocrystalline diamond (NCD) showed a good level of viability with the neural H4 line but a
poor viability with the PC12 line and lower permissiveness than 3C-SiC.
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Figure 1.7. Histogram representing results of neuronal H4 and PC12 cell proliferation
tests. The graph is expressed as the s.d.m., with error bars indicating the s.e.m., from the
three MTT assays. From [11]

The MTT analysis results for both the H4 and PC12 cell lines are displayed in Figure
1.7. The H4 cell line shows a viability level of approximately 80%+5% as compared to
the PSt control for all samples excluding Si (111) which performed at 108% +9%. Si
(100), 3C-SiC surfaces and NCD sample means were found to be statistically similar, as
well as Si(111) and PSt. Statistically significant similarities were found between 3C-SiC
samples and Si (111) when testing for PC12 proliferation, showing proliferation values of
approximately 90% of the PSt control, while the NCD and Si (100) samples were found
to be statistically similar with proliferations of 46 and 55%, respectively.
The morphology and lamellipodia attachment quality were evaluated with AFM
analysis. Figure 1.8 displays two selected AFM micrograph scans of the H4 cell line
incubated on each of the tested substrates with one scan showing a living cell and the
other a fixed cell. The H4 cells on PSt show a low level of attachment to the surface.
Figure 1.8(a) indicates that H4 cells on PSt have microtubule extensions and the average
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lamellipodia extension over the whole cell group is 28.9% of the cell area while alive.
Unfortunately, as seen in Figure 1.8(b), the lamellipodia coverage is reduced by 13.5%
after cell fixation for. The H4 cells on glass, as seen in Figure 1.8(c) for the living cell
and Figure 1.8(d) for the fixed cell, react similarly to the cells on PSt.
Although there are large expanses of lamellipodia present with many of the cells on
the glass substrate, they show very little attachment to the surface, constituting an
average of 45.5% of the cell in the living cell scans, and only 8.43% of the cell after
fixation (a 27% reduction). The H4 cells on the surface of Si (Figure 1.8(e) and 1.8(f)),
on 3C-SiC (Figure 1.8(g) and 1.8(h)), and on NCD (Figure 1.8(i) and 1.8(j)) possess
similar levels of cell attachment to the surface, but they show some differences in the
lamellipodia attachment. The H4 cells flatten and expand over a larger surface area on
these substrates. The H4 cells on Si show the lamellipodia extending from many parts of
the cell accounting for an average of 36.4% of the cell area when measured alive and
26.4% after fixation. NCD shows a slightly better lamellipodia extension and attachment
level with 30.5% of the cell area before fixation and 22.4% cell area after fixation.
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Figure 1.8. 45x45 um AFM micrographs of H4 cells deposited on different substrates.
Each micrograph possesses a pseudo three-dimensional insert in the upper right hand
corner to give some perspective on cell morphology. (a), (c), (e), (g), and (i) are H4 living
cells measured in PBS deposited on polystyrene, glass, Si, 3C-SiC, and NCD. (b), (d), (f),
(h), and (j) are H4 cells that have been fixed with 2% formaldehyde on polystyrene, glass,
Si, 3C-SiC, and NCD. From [11]

3C-SiC has the smallest measured surface area for the lamellipodia, which measured
15.1% of the living cellular area, but was the only sample group that increased in area
percentage and was 15.4% after the cell was fixed. 3C-SiC cells also show multiple large
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projections of microtubule extensions on almost all of the cells measured. The
lamellipodia reduction level for Si and NCD was 10 and 8.1%, respectively, while 3CSiC shows a mean increase of 0.3%.
The PC12 cells have much different attachment characteristics than the H4 cells and
this is most likely due to the fact that they were not changed into peripheral neurons
through the addition of neural growth factor (NGF). Glass, Si, and NCD all show lower
attachment characteristics for this cell line. Analysis of the cell height to area ratios and
attachment angles for glass, Si, and NCD, indicated that the cells are trying to minimize
their contact with these substrates which was confirmed as each of these substrates show
poor lamellipodia attachment. Although Si shows good extensions of microtubules, it has
a lamellipodia reduction of 10.2% area as indicated for the 25.0 and 14.8% live cell and
fixed cell lamellipodia measurements.
The PC12 cells on 3C-SiC have a slightly lower height to surface area ratio and a
lower angle of attachment when compared to the previous three samples. The
lamellipodia shows a much better attachment factor composing 29.3% of the cell area for
the living cell and 24.8% of the cell area for the fixed cells which amounts to only a
reduction of 4.5%. Cells on 3C-SiC also possess multiple large microtubule extensions.
The PC12 cells showed a good permissiveness with PSt, this material allows the cell to
project multiple microtubule extensions and had a 3.3% increase in lamellipodia
attachment area due to the living cell area lamellipodia percentages were 25.9 and 29.2%
for the living and fixed cells, respectively.
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Frewin's research also showed that after cell seeding and proliferation on the
substrates, the Si surface suffered physical damage that was visible through AFM
analysis of the samples, this was not the case for 3C-SiC.

1.3

Summary and Dissertation Organization
The demonstrated biocompatibility of 3C-SiC, together with its other properties, such

as mechanical and chemical resilience, the capability to built sensing devices or patterned
grafts using traditional microfabrication techniques, make this material an ideal candidate
for cardiovascular applications.
However, such applications cannot be realized until it is known for certain if this
material stimulates thrombogenic behavior that would induce thrombus formation. This
research looks to assess the hemocompatibility of this material, so that its use in
cardiovascular applications can be pursued.
The subsequent chapters explore the nature of blood, its formed elements (§3.1) and
the formation of clots and how it relates to interactions with foreign surfaces (§2.1);
additionally

we

introduce

the

different

techniques

and

rationales

behind

hemocompatibility testing (§2.2 and §2.3), and finally the results of this research by
exploring three different perspectives: platelet adhesion (§3) protein adsorption (§4) and
interactions with microvascular endothelial cells (§5).
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Chapter. 2:

Biocompatibility of Materials

A material, synthetic or natural, that is used in contact with a biological system and
that is able to co-exist without causing an unacceptable degree of harm to the system is
called a biomaterial [16].
Early biomaterials included silicone, polyurethanes, rubber, Teflon, nylon, titanium,
and stainless steel. These early materials were used to develop various types of prosthetic
devices such as biodegradable scaffolds, cochlear implants, breast implants, shoulder, hip
and knee prostheses, dental and intraocular implants, etc. Biomaterials have improved the
quality of life of many patients around the world and have provided alternatives to the
limitations of tissue rejection or limited organ donors (for the cases in which it applies).
The development of biomaterials has been full of success but also of challenges
related to material rejection or incompatibility. Most mammalian cells require attachment
to an external surface or they will experience apoptosis. The interaction of the cells and
the material at the interface must induce cell attachment and proliferation without
inducing negative morphological changes or intoxicating the cell.
Although the interaction between cells and substrates is complex and it is regulated
by the interactions of the material with the extracellular matrix, cell membrane, cell
cytoskeleton etc., it is widely accepted that a cell in contact with a biocompatible material
will attach to and spread out on the surface and then proliferate, thus making cell
morphology and viability good measurements of biocompatibility [11] [37] [38]. Cells on
a non-permissive surface will interact with the substrate by decreasing their attachment
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area due to flow back of actin filaments from the cytoskeleton into the central core of the
cell [37] [39].
Unfortunately, the above concepts of viability and morphology as a measurement of
biocompatibility cannot be extended to the interaction of materials and blood. If a blood
contacting material allows blood organelles to attach and spread on its surface, this would
alter the normal blood flow, create turbulence and ultimately induce thrombus formation.
Thrombus formation has life threatening consequences for the patient due to thrombus
embolization and must be avoided at all cost.
Therefore a new set of concepts to describe the biocompatibility of a substrate with
blood must be utilized. The following sections of this chapter describe these concepts and
the different perspectives on hemocompatibility evaluation.

2.1

Biocompatibility of Materials with Blood: Hemocompatibility
Hemocompatibility concerns to the properties of materials suitable for blood

contacting applications. Blood contacting devices range from needles to vascular grafts,
cardiopulmonary bypass and heart valves among others. Highly invasive devices usually
extend the life of patients and perform reasonably well for periods of time before clinical
complications can be observed. These devices also require post-implant clinical
treatments, like the use of blood anticoagulants. Today's blood compatibility philosophy
is to guarantee the safety of the implant and to minimize post-implant procedures which
finally represent long term benefit for the patient. [1] [40] [41].
The most common device/material failures due to a lack of hemocompatibility are
related to thromboembolic complications. Other complications of prosthetic devices in
contact with the blood stream include erosion of the material, mechanical failure and
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nonstructural dysfunction, hemolysis and infection. However, for the purpose of studying
hemocompatibility, it is important to focus on reactions that are specific to the placement
of a material in contact with blood and not to those that may be the result the activation of
the multiple defense mechanisms that the body has available in response to the presence
of foreign devices [42] [43] [44]. These specific reactions are called thrombotic and
thromboembolic complications. To study hemocompatibility is related to the study of the
thrombogenic behavior of a material; a material with low thrombogenicity will be
therefore more hemocompatible and will also reduce the risk of bleeding associated with
the use of blood thinners [45] [46] [40].
To date a man-made material that is purely hemocompatible has not been reported,
and the mechanisms behind surface-blood interactions have not been completely
understood. Indeed, it may be this later point that has made the development of a truly
hemocompatible material so difficult.
Smooth polymeric surfaces have been used as a coating for materials used in blood
pumps and they have shown that roughness seems to play an important role in
hemocompatibility. Since the introduction of these polymeric coatings, based on the use
of anticoagulants like heparin or thrombin inhibitors [47] [48], two approaches have been
used to address the subject of surface-blood interactions. First, the creation of a
pseudointima formed from the blood lining and, second, the reduction of blood formed
elements and protein interactions with the surface. A material that has a high
compatibility with endothelial cells and that possesses low thrombogenicity, ultimately
expressed in fewer platelet adsorption, aggregation and activation, would satisfy both
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approaches and would be desirable for the development of long-term cardiovascular
devices [7] [46].
The ISO 10993-4 standard introduces the different rationales that must be used when
evaluating a material for its hemocompatibility. Next we explore some of the key points
of this important document.

2.2

Standard ISO 10993-4
The relevant standard for this research, ISO 10993, defines blood/device interaction

as any interaction between blood or blood components and a device resulting in effects
on the blood or on any organ or tissue, or on the device [49] [50].
When testing a material for its hemocompatibility, several considerations, such as
duration of contact, temperature, sterility, flow conditions, sample collection/storage,
enzymes, controls, surface to volume ratio and fluid dynamic conditions (flow rates),
among others, have to be taken into account. Tests should be performed with minimal
delay, usually within 4 hours of blood withdrawal, since some properties of the blood
change rapidly after collection [51] [50].
Additionally, in the case of a specific geometry, the ratio of the test parameter to the
exposed surface area must be evaluated (Concentration per unit volume/cm2) [51] [50]
[52].
The use of animal models for screening purposes is encouraged, but the interpretation
of the results must be done carefully, considering that results may be different in human
models, given the differences in blood reactivity between species, as well as the fact that
differences between in vitro and in vivo models will most probably exist. For example in
vitro hemocompatibility does not guarantee in vivo hemocompatibility [49] [51] [53].
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ISO 10993-4 provides a test-selection system that is based on clinical concerns. The
types of tests required by this standard depend on the blood contact category of the
device or material (external communicating devices—blood path indirect, external
communicating devices—circulating blood, and implant devices) [52]. For each contact
category tests are recommended from the following list of general test categories:
thrombosis, coagulation, platelets/platelet function, hematology, and immunology, as
shown in Table 2.1 for in vitro testing [52].
Table 2.1. A sample of primary in vitro tests, Adapted from [51].
Copyright remains with ISO
Test Category
Method
Comments
Thrombosis
Adhered platelets,
Light Microscopy or
Platelet count,
Scanning Electron
leukocytes, aggregates, Microscopy
erythrocytes, fibrin, etc.
Coagulation
Partial thromboplastin
time
Hematology
Leukocyte count;
Hemolysis is
hemolysis (plasma
performed to measure
hemoglobin)
the red blood cell
membrane fragility in
contact with materials
and devices.
Hematology
Leukocyte count and
Hemolysis screening
differential; hemolysis test is performed
(plasma hemoglobin)
because of its
measurement of red
blood cell membrane
fragility in contact
with materials and
devices. The method
used should be one of
the normative
standard test methods
for hemolysis.
Immunology
C3a, C5a, TCC, Bb,
A panel including the
iC3b, C4d, SC5b-9
last four tests
encompasses the
various complement
activation pathways.
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In order to maximize the hemocompatibility information about a device, one or more
tests from Table 2.1 should be performed. Unfortunately, in the absence of standardized
and validated test methods, the requirement for testing across all categories is frequently
ignored [52].
Complement activation is the most important immunology test for circulating-blood
contact devices/materials; this test reveals the activation of the complement cascade [41].
ASTM F 756, a standardized ASTM hemolysis test method, is used to determine the
hemolytic potential of a device or material; an increase in plasma hemoglobin correlates
with lysis of red blood cells, thereby indicating hemolytic activity of the material exposed
to the cells. A device's effect on blood coagulation may be measured in vitro by
determining the rate of clot formation or the partial thromboplastin time (PTT) test of
plasma exposed to the biomaterial or device during an incubation period. The reaction of
white blood cells to materials can also be used as an effective hematology test [52].
However, the first step in determining the degree of hemocompatibility of a material
is to evaluate thrombogenicity and compatibility with the cells of the blood vessels lining,
as low thrombogenicity and low compatibility with the vessel cells would not justify
testing for hemolysis, complement activation and immunologic responses or would
require in-vivo or ex-vivo testing.

2.3

Perspectives in Hemocompatibility Assessment
Previous research regarding the bio and hemocompatibility of materials have shown

interest in amorphous SiC, porous SiC, crystalline silicon, polysilicon, Diamond-like
carbon (DLC), polymers, heparin coatings, titanium, chromium and different oxides [8]
[12] [35] [46] [54] [55] [26] [56].
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As both Si and SiC have shown good biocompatibility for tissue proliferation they
have drawn interest for hemocompatibility research, however, most of all the documented
research regarding hemocompatibility of SiC is limited to amorphous SiC, 4H-SiC, 6HSiC and porous SiC (4H-SiC and 6H-SiC) [57]. Also, in many of these studies SiC is not
compared directly to Si which is still the leading material for biomedical sensors.
To the best of our knowledge, this is the first research that directly compares single
crystal 3C-SiC with Si (100), and explores if the low thrombogenic behavior of
amorphous SiC extends to its single crystal (i.e., 3C-SiC) polytype.
Hemocompatibility of amorphous hydrogenated SiC (a-SiC:H) has been tested mostly
as a coating made by Plasma Enhanced Chemical Vapor Deposition (PECVD) [8] [55],
these coatings have shown less protein adhesion and aggregation when exposed to whole
blood than Si and silicon-rich surfaces which tend to absorb more albumin [58]. Chances
of protein biofouling directly associated with the capacity of a material to adsorb
proteins, and protein adsorption seems to decrease with increased concentrations of
carbon.
In [58] it was shown than silicon and silicon nitride had higher platelet adhesion than
silicon dioxide, paralene or SU-8 polymers, unfortunately they did not include SiC in
their study. Polyethylene glycol has been grafted to silicon in the past to decrease the
protein binding and platelet adhesion of silicon surfaces [28] [59] [60]. It has been shown
that amorphous SiC coatings have low levels of fibrinogen and fibrin (proteins that
promote clot formation) adsorption when contacting blood, thus making SiC coatings,
resistant to platelet adhesion [61] [21]. Consistent results have been found when
comparing amorphous SiC coatings to Ti. It is not known if the clot resistance of PECVD
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deposited a-SiC coatings will translate to single crystal 3C-SiC films grown on Si
substrates.
In [54] a direct comparison of silicon wafers and a-SiC-coated (PECVD) silicon
wafers was performed, In this study both materials seemed to be outperformed by
diamond-like coated silicon wafers which presented less clot formation.
Additionally,

a

microvascular

approach

has

been

introduced

in

many

hemocompatibility studies, as this is the level where the cellular interactions responsible
for hemocompatibility take place. This microvascular approach is related to the
assessment of microvascular endothelial cell proliferation on the surfaces of interest [21]
[62] [63] [64]. DLC and Si doped DLC films and coatings have been shown to have good
compatibility with human microvascular endothelial cells (HMVEC), and decreased
platelet adhesion. It was also shown than graphitization of these films reduces HMVEC
attachment and increases platelet adhesion [21].
The evaluation of endothelial cell proliferation has been used as a standard to
evaluate the hemocompatibility of vascular grafts, and it has been used to evaluate Si and
plasma modified polyethylenerephthalate (PET) substrates,
The study of the opposing but complementary nature of the behavior of platelets and
endothelial cells for a particular biomaterial can therefore provide valuable insight about
its hemocompatibility [21].
From all the above, it can be concluded that the perspectives in the evaluation of the
hemocompatibility of a material can be classified, at least for initial exploration, into
three types: 1) the evaluation of platelet adhesion and aggregation to the substrates of
interest, 2) the evaluation of the adsorption of the protein related to platelet adhesion to
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the surfaces and 3) the study of microvascular endothelial cell proliferation on these
surfaces.

2.3.1

The Platelet Adhesion and Activation Assessment Perspective

The deadly complications associated with the formation of a fibrin-platelet thrombus
(i.e. arterial or pulmonary embolization) when inserting a blood contacting device into
the blood stream, or the risk of device malfunction, make assessment of the behavior of
platelets in contact with a material a topic that is gaining increased interest.
Platelet adhesion, lamellipodia and filopodia formation, aggregation, and spreading
precede the formation of a thrombus and these markers have therefore been used as a
measure of a material’s thrombogenicity [58] [65] [66] [67] [68].

Figure 2.1. Scanning electron micrographs showing platelet morphology of Si (left) and
SiO2 (right). Images taken at 1200 x 0.15kV [58]
Figure 2.1 illustrates, from the study in [58], the adhesion of platelets to Si and SiO2. The
images reveal morphological changes of platelets (pseudopods formation) that indicate
activation and aggregation.
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Figure 2.2 shows how in [58] platelet adhesion was used to quantitatively compare
various material used in Bio-MEMS devices. The results confirmed higher levels of
thrombogenicity for Si and the lowest value of platelet adhesion for polyurethane [69].
platelet circularity and spreading (area) have also been reported as more specific
measurements of hemocompatibility. When a platelet activates, it starts spreading on the
surface and developing pseudopods, changing consequently its circular shape from the
resting state. The less circular the platelets are that adhere to a surface, the more
thrombogenic the material is [68].

Figure 2.2. Number of adhered platelets per 15 mm2 for Si, Si-based materials, SU-8,
parylene and polyurethane. # Statistically different from Polyurethane and * statistically
different from Si [58].

In contrast with other blood formed elements, platelets are not normally in stable
contact with each other, but they develop such contacts once aggregation has started,
limiting the escape of platelet activators from within the gaps between them. This helps
to create and prevent the dissolution of the haemostatic plug [70]. Therefore the degree of
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aggregation also provides important information about the thrombogenic behavior of the
material, even when activation is not present [71].

2.3.2

The Protein Adsorption Assessment Perspective

When injury is present in the vessel wall, it initiates the expression of tissue factor
activity. Platelets rapidly accumulate on the endothelium, and fibrin can be observed at
the platelet thrombus–vessel wall interface, at the leading edge of the thrombus. The
same concept applies for thrombus formed on the surfaces of a material, with adhesion
plasma proteins being adsorbed to the surface and fibrinogen being transformed to fibrin
by the action of thrombin.

Figure 2.3. Fibrinogen promoting platelet-platelet adhesion by binding glycoprotein IIbIIIa (GPIIb-IIIa). Adapted from [70]

Fibrinogen and the Von Willebrand factor are thought to play a key role in platelet–
vessel wall interaction, particularly at low shear rates. Deficiencies in fibronectin delayed
the formation of thrombus in in- vivo experiments performed on modified rats [70].
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The short distance between platelets leads to aggregation when by direct interaction a
multivalent adhesive proteins (i.e. Fibrinogen) link activated glycoprotein IIb-IIIa
(GPIIb-IIIa, the major platelet membrane integrin) on the surface of platelets adjacent to
other platelets or promoting platelet adhesion to artificial surfaces (see Figure 2.3).
However, there are multiple plasma proteins and participants of this platelet-surface
(material or vessel wall) interaction, including albumin and collagen that are directly
implied in thrombus formation [70] [14] [61] [72]. However in-vitro applications look for
the minimum amount of variables possible and usually limits the study of plasma protein
interactions with surfaces to either fibrinogen or fibronectin [72].

2.3.3

The Endothelial Cell Proliferation Perspective

Antithrombogenic polymeric coatings have been widely used to improve the
hemocompatibility of materials [73]. However a new trend is to coat the material with the
natural Antithrombogenic surface of the human body: Vascular endothelial cells.
As stated before the relationship between endothelial cells and platelets is opposite in
nature but complementary. A material that has low platelet adhesion usually has very
good endothelial cell proliferation, and these two requirements must be fulfilled for a
material to be considered hemocompatible for real applications [74]. Endothelial coatings
have been tested in the past on modified DLC surfaces with the purpose of using it in
vascular grafts and heart valves but this requires the substrate in which the endothelial
cells are been seeded to be compatible with these cells.
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Figure 2.4.SEM micrographs showing endothelial cells on three types of Cr-DLC. Cr is
1,5 and 10% [62]

Cr-DLC compatibility with human vascular changes as a function of the percentage
of chromium in the film has been studied in [62]. Figure 2.4 shows that DLC with 5% of
Cr was the only for which endothelial cells presented good morphology. All the other
percentages shown agglomerations, lack of spreading, and poor generation of
lamellipodia and filopodia typical of HMVEC.

Consistently, the surfaces with bad

morphology presented lower proliferation. It was concluded that 5% Cr-DLC is more
hemocompatible than the other variations analyzed in this study. This is an example of
how microvascular endothelial cell proliferation can be used to asses hemocompatibility.
However, using only this information is incomplete, as good endothelial cell proliferation
must complement low platelet adhesion for a hemocompatibility statement to be made.
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Chapter. 3:
3.1

Platelet Adhesion and Activation

The Blood and its Elements
Blood is a bodily fluid that constitutes about 8% of the body's weight, it circulates

through the heart and vessels transporting oxygen and nutrients to the different tissues
and organs of the human body and transporting waste products away from them. It is
through a blood mechanism called coagulation that the body heals itself and prevents
excessive bleeding after injury. Blood also executes many immunological (activation of
the complement system that leads to inflammation and foreign body encapsulation) and
regulatory (pH and temperature) functions in the human body [75] [15].
Blood is constituted of plasma (55%) and formed elements or organelles (45%).
About 92% of the plasma is water and 7% proteins (albumin, globulin, fibrinogen, etc.)
and the remaining are electrolytes, glucose, amino acids, fatty acids, organic nutrients and
waste [75] [15].
The normal pH of arterial human blood is approximately 7.4. The term blood serum
refers to plasma without clotting factors (i.e., fibrinogen). Blood formed elements include
erythrocytes (red blood cells), leucocytes (white blood cells) and thrombocytes
(platelets). About 99% of the blood organelles are red cells [75] [15].
Mature red cells in mammals do not have a nucleus. Red cells are produced in the
bone marrow and usually lose their nuclei when they are released into the blood stream,
in order to provide more space for hemoglobin. After being released red blood cells live
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for about 100-120 days. Mammalian erythrocytes are flexible biconcave disks: flattened
and depressed in the center, with a dumbbell-shaped cross section (see Figure 3.2). A
typical human erythrocyte disk has a diameter of 6–8 µm and a thickness of 2 µm, about
one third of the volume of a red cell is hemoglobin, responsible for the transport of about
98% of the oxygen in the human body [75] [15].

Figure 3.1. Diagram of a red blood cell (erythrocyte) shape,
in plan and cross section [75].

White cells or leucocytes are the cells of the immune system and there are at least five
types of them. Unlike red cells, white cells retain their nuclei. White cells are divided into
granulocytes (also known as polymorphonuclear leucocytes) and mononuclear cells.
There are three types of granulocytes and two types of mononuclear cells, see Figure 3.2.

Figure 3.2. Classification of the 5 types of white cells [75].
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Neutrophils are attracted to sites of infection (chemotaxis), and destroy the microorganisms (mainly bacteria and fungi) responsible for the infection by ingesting them
through a process known as phagocytosis. Eosinophils target parasitic infections and also
play a role in allergic reactions. Basophils have a role in immediate hypersensitive
reactions and allergic and inflammatory responses.
Mononuclear cells include lymphocytes and monocytes. Lymphocytes mediate
immune responses and are classified into three types: B, T and natural killers (NK). B
lymphocytes secrete antibodies to work against antigens as part of the humoral immune
response. T lymphocytes attack cells bearing foreign antigen and antibody coated cells
playing a key role in the cell-mediated immunity. NK cells reject tumors and attack cells
infected by viruses; they play a role in cell-mediated immunity and are a major
component of the innate immune system.
Monocytes migrate to tissues where they differentiate into tissue resident
macrophages or dentritic cells. Macrophages phagocytose cellular debris and pathogenic
microorganisms and stimulate lymphocytes and other immune cells that respond to the
pathogen. Dentritic cells present the antigens to the T lymphocytes in order to activate
them.
Another formed element in the blood are platelets. Platelets are formed by the
fragmentation of the protruding cytoplasm of megakaryocytes (large bone marrow cells)
in the sinusoids of the bone marrow. Therefore they are not cells but fragments of cell
cytoplasm of discoid shape. The average life span of a platelet is 7 days and they range
from 2 µm to 3 µm in diameter by 0.5 µm in thickness [76]. Their small size and discoid
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shape allows the blood flow to push them to the vessel edge, near the surface of the
endothelium were they are ready to detect and respond to vascular damage.
Platelets play a key role in hemostasis leading to the formation of blood clots when in
contact with activating factors. Clot formation requires platelets to undergo rapid
morphological changes from a resting state to an activated state, as well as platelet
aggregation, as shown in Figure 3.3.

Figure 3.3. Scanning electron microscope images of resting (left), partially (center) and
fully activated (right) human platelets. From [77].

The shape of the platelets is maintained by a sturdy and flexible internal cytoskeleton
composed of actin and tubulin polymers and their associated proteins [5]. Remodeling of
the cytoskeleton and assembly of new actin filaments allows for platelet shape changes.
The surface of the platelets is featureless except for semi-selective conduits formed from
membrane invaginations that allow small molecules to enter the platelet membrane.
Platelet cytoplasm is composed of normal cellular organelles (lysosomes, mitochondria,
etc.) and additionally contains specific platelet granules, the α-granules, which store
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matrix adhesive proteins and have glycoprotein receptors in their limiting membranes in
order to promote adhesion between platelets and the matrix.
When blood is collected in tubes containing anticoagulant solution (otherwise it
would create a single solid clot) and it is allowed to settle, it separates into three layers,
see Figure 3.3: The bottom layer is composed of red cells, the top layer is clear and pale
yellow and is the blood plasma. In between is a narrow layer called the buffy coat
composed mainly of white cells and platelets [75] [15].
If it is necessary to isolate platelets from whole blood, two major methods are
available: the platelet rich plasma (PRP) and the buffy coat (BC) methods, illustrated in
the diagrams of Figure 3.4.

Figure 3.4. Diagram of a tube of anticoagulated blood that has settled, illustrating the
separation of blood into three layers. Adapted from [75]
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Figure 3.5. Preparation of platelet concentrates using the PRP and BC techniques [15].

Both techniques are based on the concept of differential sedimentation, which is
manipulated via centrifugation. The sedimentation rate is influenced heavily by the
physical properties of the cells and the viscosity of the medium, in this case, plasma [15].
In the PRP technique, anticoagulated whole blood first undergoes low G-force
("soft") centrifugation which results in a PRP supernatant that contains mostly suspended
platelets( plus 30-50% of white cells and some red cells). The red cells form a pellet in
the bottom of the test tube with the remaining white cells and some platelets. The PRP
can be centrifuged at high G, to separate platelet-poor plasma from the plateletconcentrate pellet that can be resuspended to the desired density [15].
High speed (hard) centrifugation separates blood differently from low speed
centrifugation. At high speed, the white cells sediment with red cells initially, leaving in
the top a PRP supernatant. Then red cells are packed closely and fall to bottom rapidly,
which forces white cells upward at the plasma interface, which is a process that is
followed by platelet sedimentation at the white cell layer. The former describes the first
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step of the BC method. Subsequently the buffy layer containing white cells and platelets
is centrifuged at low g, resulting in dense platelet rich plasma [75] [15].
Appropriate selection of the centrifugation speed and centrifugation time may result
in a PRP supernatant, an intermediate white cell layer and a red cell pellet.

3.2

Platelet Adhesion and Activation Assessment Protocol
Platelet reactivity, measured by the degree to which platelets in suspension adhere to

a surface in vitro, has been proposed as a measure of thrombogenicity [58]. This includes
the amount of platelet adhesion as well as changes in platelet morphology including
increased area and development of pseudopods. Platelet circularity, C, is defined as
C  4

A
, where P is the perimeter of the platelet and A is its area. When the platelet
P2

possesses perfect circularity C is equal to unity [78] [58].
It has been observed that an increase in platelet circularity on a material correlates
with increased hemocompatibility of the material surface [58]. It has also been noted that
an increase in platelet area represents a decrease in hemocompatibility of the surface (this
is consistent with the above as the platelet tends to form a tight circular shape when not
adhering to the surface thus minimizing its area). Therefore platelet spreading (i.e.,
increase in platelet area) and circularity have been reported as specific markers for
surface hemocompatibility.
In order to evaluate platelet reactivity on 3C-SiC, 4H-SiC, 6H-SiC and Si samples the
following protocol was followed. Blood samples were obtained from young, healthy,
female farm pigs weighting approximately 45 kg, free of hepatitis or other blood borne
disease. The blood samples were collected by routine phlebotomy using 4.5 ml BD
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Vacutainer blood collection tubes (blue stopper) containing 0.105M (3.2%) buffered
sodium citrate (12.35mg of sodium citrate / 2.21mg of citric acid) for anticoagulation.
The anticoagulant effect of sodium citrate is reversible, allowing the platelets to activate
when in contact with a thrombogenic (i.e., non hemocompatible) material.
Platelet rich plasma (PRP) was obtained from the blood samples via centrifuging the
tubes for 20 minutes at 200g and at room temperature. The platelet concentration was
calculated using bright line counting chamber (hemocytometer) with reduced thickness
from Hausser Scientific and a BD Unopette™ system, designed especially for platelets
and leukocyte counts. The average platelet concentration was 4.38 x 105 platelets/ml. The
PRP samples were then incubated for 30 minutes at 37°C to allow the platelets to recover
their shape which is necessary for platelet interactions and activation.
Single crystal 3C-SiC samples grown on Si(100) and single crystal Si(100) wafer
samples (die size 10mm x 8mm) were cleaned for 10 minutes via piranha solution
(organics removal) at 2:1 concentrations of H2SO4: H2O2, then rinsed three times with
deionized water (DI-water) with a resistivity of at least 16 MΩ·cm, followed by 5
minutes of H2O:HCl in a 1:1 ratio, intended to eliminate any sulfur traces resulting from
the piranha cleaning. Native surface oxide was removed by dipping the samples in a
hydrofluoric acid solution (50:1 H2O:HF) for 1 minute. The samples were then
thoroughly rinsed in DI water and stored under ethanol. Just prior PRP exposure, the
samples were rinsed three times with DI-water and manually blow dried with nitrogen.
4H-SiC and 6H-SiC samples were obtained from wafers purchased from Cree Inc.
4H-SiC, 6H-SiC and Si samples underwent the same cleaning procedure already
described for 3C-Sic samples.
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The clean and dry semiconductor material samples were them placed in BD Falcon
24-multiwell culture inserts and covered with 2 ml of PRP. The multiwell plates were
then placed in the incubator for 15 minutes at 37°C and 5% CO2 and 95% relative
humidity.
The wafer die were then removed and rinsed twice with PBS (Phosphate buffered
saline) to remove non adherent platelets, and then the platelets were fixed using 4%
paraformaldehyde in PBS. The samples were rinsed again two times and then dipped for
30 minutes in a 0.1% Triton-X solution in order to permeabilize the membrane of the
adherent platelets. After rinsing, the fixed platelets were pre-incubated in PBS containing
1% BSA (bovine serum albumin) in order to reduce nonspecific background staining.
Next, the F-Actin filaments of the platelets' cytoskeleton was stained using Rodhamine
Phalloidin (R415 from Invitrogen™), a cellular structure probe made from a phalotoxin
conjugated to the orange-fluorescent dye, tetramethylrhodamine (TRITC) also diluted in
1% BSA solution. Cover slips were mounted over the samples using DAPI (4',6diamidino-2-phenylindole), a nucleic acid fluorescent stain, in order to differentiate
platelets from any unintentionally present cells derived from the PRP separation process.
Subsequently, the samples were imaged using a Leica DM IL inverted microscope at
different levels of magnification, and the images were manually processed to enhance
borders and backgrounds and then automatically processed (thresholding, noise
reduction, etc.) and analyzed using ImageJ, a public domain image processing software
developed at the NIH (National Institutes of Health) [79].
Previous research regarding platelet adhesion, and activation were usually performed
in the absence of aggregation, either chemically manipulating the PRP (for example
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adding EDTA) or by exposing the surfaces to PRP only for 5 minutes [58] [80].
Additionally the PRP is diluted to guarantee a low number of platelets adhered to the
surface and this way images of single activated platelets are easier to obtain [81].
Although this approach allows the acquisition of single activated platelet images it may
be detrimental to the experiments as it can yield falsified results making it hard to know if
low adhesion and activation is just a consequence of low platelet surface interaction, it
also prevents one from getting a better picture of platelet clumping in the presence and
absence of activation [81].
In this experiment the samples were exposed for longer times (15 minutes), at high
platelet concentrations and without PRP manipulation to avoid aggregation, in order to
get a better insight into the thrombogenic behavior of the studied surfaces. Subsequently,
these conditions resulted in a higher level of difficulty when analyzing the images, as the
presence of clumps and the facts that platelets do not have a constant size and that their
shape is discoid required more complex image processing (manual and automatic) in
order to facilitate particle differentiation when possible (see Figure 3.6).

Original Image

Thresholding and
eroding

Manual edition

Automatic particle
detection and analysis

Figure 3.6. Illustration of the image analysis process for platelets seeded on a Si sample.
The original image cannot be adequately processed by the software. The image is first
manually enhanced and then automatically prepared for particle detection and analysis
with ImageJ [79]
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Higher platelet adhesion was observed on the Si surface than on SiC, and among the
SiC polytypes it can be seen that more adhesion occurred for the hexagonal types than the
cubic (i.e., 3C-SiC) type. More importantly, when looking at high magnification it was
found that the platelets that adhered to the 4H-SiC and 6H-SiC surfaces had more
activation (presence of lamellipodia and filopodia) and presence of clumps than for 3CSiC and Si. 3C-SiC surfaces showed less aggregation and activation with much more
circular shaped platelets that the other surfaces thus indicating an improved
hemocompatibility. The former is illustrated in Figure 3.7.
3C-SiC/Si(100)

4H-SiC

6H-SiC

100x

40x

Si(100)

Figure 3.7. Fluorescent micrographs comparing adhered platelets on 3 different SiC
polytypes and Si. 3C-SiC clearly shows lower adhesion and high circularity while Si
presented the highest adhesion. 4H-SiC and 6H-SiC evidenced the presence of clumps
and high degree of activation

4H-SiC presented, as shown in Figure 3.8., large-area activated particles and nonactivated/activated platelet clumps and the highest adhesion of all the SiC polytypes
included in this study, exhibiting therefore a thrombogenic behavior that can lead to
device failure.
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100x

Figure 3.8. Fluorescent micrographs revealing activated platelet clumps (left), nonclumped activated platelets (center) and a large non-activated platelet clump on the
surface of 4H-SiC samples. Magnification 100x

The results of these experiments were evaluated for statistical significance using
analysis of variance (ANOVA) to detect significant differences among all pairs of means
of the markers circularity, particle adhesion counts, and particle size (this will indicate if
at least one pair of mean values is statistically different). However, this technique does
not single out any particular pair of means as being statistically different. In order to
address this problem for the cases in which the F-test indicated that at least one of the
means was different, a multiple comparison using paired T-tests with Bonferroni
adjustment was used. The tests were evaluated for a significance level of 5% (α=0.05).
Due to the presence of platelet aggregation the resulting statistics cannot be
interpreted in a deterministic way in order not to misinterpret particle analysis. For
example a very circular clump where platelets cannot be differentiated is going to yield a
big size (false platelet size), and in this case circularity is not significant compared to
size, that indicates the presence of clumps. Similarly, a low number of counts, but high
size, indicates the presence of a few big clumps, where individual platelets cannot be
differentiated automatically by the software. A low-thrombogenic material should present
low counts of adhered platelets with high circularity and small average size.
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Bar diagrams and ANOVA analysis tables for circularity, adhesion and platelet area
(size) are shown in Figures 3.9, 3.10 and 3.11 respectively. Platelet circularity for all the
samples was above 0.85 which is considered a high value and indicative of low activation
[78]. The highest average value was for 3C-SiC with a confidence interval of [0.939 +
0.049] also with the smallest standard deviation. However, when testing for statistical
differences a high p value of p=0.0746 showed no significant differences among the
platelet circularity for the different materials. This also suggests that the samples have
similar variances and therefore the presence of outliers in the circularity measurements
for 4H-SiC. This indicates that the results of circularity, particle counts and size should
be analyzed together to understand the thrombogenic behavior of this material. 4H-SiC
presented high circularity but small particle count (comparable to 3C-SiC and 6H-SiC, as
confirmed by paired-adjusted test), particles that also presented the highest average size
with the highest variance. This can be interpreted as the particles not being individual
platelets, but large size circular clumps that the software is not able to differentiate as
multiple particles regardless of any image enhancement done previously, leading to
platelet miscounts. Looking at the circularity alone, it would lead us to think of 4H-SiC
as a low thrombogenic material, however this cannot be further from the truth, and a
composite analysis of the statistical data confirms the optical results illustrated in Figures
3.7 and 3.8.
Additionally, it can be concluded that mathematically small differences in circularity
are good indicators of the initial stages of activation, even though they may not be big
enough to translate into drastic statistical indicators of variability among the samples. For
example, the confidence intervals of circularity for 3C-SiC and Si were [0.939 +0.049]
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and [0.885 +0.053] which is a small difference with no statistical significance, but optical
comparison of Si and 3C-SiC (Figure 3.12) shows that platelets adhered to Si are more
activated than the ones adhered to 3C-SiC, however they are in an early stage of
activation which must be considered when drawing conclusions from this data.
6H-SiC or 4H-SiC had comparable average circularity but also higher variability,
which was associated either with the presence of circular clumps or with the presence of
deformed clumps or individual highly activated platelets.
Statistical paired analysis of the particle counts indicated no statistical differences
between 3C-SiC and 6H-SiC; however platelets that adhered to 3C-SiC showed higher
circularity and smaller area while 6H-SiC evidenced the presence of activated clumps. Si
surfaces evidenced the highest platelet adhesion of all the surfaces with high presence of
clumps (large size particles), thus

showing consistently a lower level of

hemocompatibility.
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Figure 3.9. Statistical analysis of particle circularity on 3 different SiC polytypes and Si.
Top: Histogram. Bottom: Anova table.
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Figure 3.10. Statistical analysis of particle counts on 3 different SiC polytypes and Si.
Top: Histogram. Bottom: Anova table.
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Figure 3.11. Statistical analysis of particle size on 3 different SiC polytypes and Si. Top:
Histogram. Bottom: Anova table.

Si(100)

100x

3C-SiC/Si(100)

Figure 3.12. Fluorescent micrographs comparing Si (left) and 3C-SiC (right) samples
revealing higher degree of thrombogenicity in Si than in 3C-SiC. Si samples presented
higher adhesion, activation and aggregation than 3C-SiC samples.
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3.2.1

The Impact of Surface Roughness

Surface roughness is considered a key factor in determining a low-thrombogenic
behavior of biomaterials. Although the mechanisms behind hemocompatibility have not
been completely understood yet, it is largely accepted that blood cell lysing due to high
surface roughness can induce a thrombogenic reaction but more importantly that surface
roughness has an impact on surface wettability and protein adsorption [82] [83] [34].
In order to assess the effect of surface roughness on platelet reactivity to 3C-SiC,
several samples of high and low roughness were used, with different degrees of
crystallinity and crystal orientation: single crystal 3C-SiC samples grown on Si(100)
showing low roughness, Polycrystalline 3C-SiC grown on Si(100) showing high
roughness, and single crystal 3C-SiC grown on Si(111) evidencing both high roughness
and low roughness in different parts of the wafer, see Figures 3.13-3.17. Table 3.1
summarizes the range of values used for roughness assessment of the different samples.
The silicon samples were used as controls for comparison and its roughness has
average values smaller than single crystal 3C-SiC and a small standard deviation,
indicating less variability of the surface morphology.

Table 3.1. Summary of samples roughness expressed as
[average roughness(µ) + standard deviation of the mean(σ)] in nanometers (nm)
Sample
[µ+σ] (nm)
Single crystal 3C-SiC/(100)Si
Polycrystalline 3C-SiC/(100)Si
Single crystal 3C-SiC/(111)Si
(low Roughness)
Single crystal 3C-SiC/(111) Si
(high roughness)
(100) Si
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0.248167 + 0.112642
62.31167 + 17.38315
4.215833 + 1.525045
34.0165 + 16.6633
0.074 + 0.087681

Figure 3.13. AFM micrograph taken in tapping mode. Example of sample with low
roughness: single crystal 3C-SiC/(100)Si (from wafer USF1-08-013- die #9)

Figure 3.14. AFM micrograph taken in tapping mode. Example of sample with high
roughness: polycrystalline 3C-SiC/(100)Si (from wafer USF2-06-074- die #4)
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Figure 3.15. AFM micrograph taken in tapping mode. Example of sample with low
roughness: single crystal 3C-SiC/(111)Si (from wafer USF -U die #9)

Figure 3.16. AFM micrograph taken in tapping mode. Example of sample with high
roughness: single crystal 3C-SiC/(111)Si (from wafer USF -U die #4)
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Figure 3.17. AFM micrograph taken in tapping mode. Silicon (100) sample exhibiting
low roughness.

The protocol used to evaluate the effect of surface roughness was the same as
described in Section 3.3. After fluorescence microscopy of the stained platelets at
different levels of magnification, it was observed that there is a high density of clumps
for the high-roughness surfaces that is independent of crystal orientation and surface
morphology, Figure 3.19.
Low-roughness surfaces on the other hand evidenced interesting results, as shown in
Figures 3.18 and 3.20. Figure 3.18 compares two low roughness surfaces, with different
orientations, the optical results indicate that for comparable roughness, crystal orientation
may have an impact on platelet reactivity. Figure 3.20 shows high platelet adhesion,
activation and clump formation on a low-roughness Si surface; comparison of these
images with the left images in Figure 3.18 indicate higher reactivity of Si versus 3C-SiC,
this is, for identical conditions (both single crystal, same orientation and low roughness)
which can be explained by the fact that silicon surfaces are considerably more
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hydrophobic than the SiC surfaces [9]; it is a well known fact that adhesion proteins
adhere preferentially to hydrophobic surfaces [84].

Single crystal 3C-SiC/Si(111)

100x

40x

Single crystal 3C-SiC/Si(100)

Figure 3.18. Fluorescent micrograph comparison of two low-roughness surfaces.
Left: single crystal 3C-SiC/Si(100). Right: single crystal 3C-SiC/Si(111)

55

Single crystal 3C-SiC/Si(111)

100x

40x

Polycrystalline 3C-SiC/Si(100)

Figure 3.19. Fluorescent micrograph comparison of two high-roughness polycrystalline
3C-SiC surfaces. Left: Grown on a Si(100) substrate. Right: Grown on a Si(100)
substrate

40x

100x

Figure 3.20. Fluorescent micrograph of platelet adhesion on a low-roughness silicon(100)
surface
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Unlike the previous experiment, no particle analysis was derived from the images, as
the high density of adhesion and aggregation for all the surfaces, except for the single
crystal 3C-SiC/Si(100) would only result in falsified statistics.

3.3

Discussion
Platelet adhesion and morphology were assessed after the exposure of PRP to

different SiC polytypes, different crystal orientations and surface roughnesses and the
results were contrasted to those of Si(100) wafer die. The information obtained from
these experiments was evaluated qualitatively, by optical (fluorescent microscopy)
inspection, and quantitatively, by obtaining specific information from the images and
then performing statistical analysis.
In each case single crystal 3C-SiC grown on Si(100) substrates had the best
performance, with low particle adhesion counts and small-area adhered platelets that also
showed high platelet circularity. The former characteristics are highly desirable for
cardiovascular applications as they display low thrombogenicity and reduce the chances
of catastrophic failure of a device due to thrombi embolization.
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Chapter. 4:
4.1

Protein Adsorption to Surfaces

The Aggregation and Activation of Platelets
Platelet aggregation is a key event in the process of thrombus formation, which

results from a series of coordinated cell adhesion events. Circulating platelets are initially
tethered to subendothelial matrices exposed at the vascular injury site, followed by stable
platelet adhesion to the subendothelium, and adherence of additional platelets to the
surface of platelets already adhered, leading to platelet aggregation. This sequence is
mediated by specific receptor-ligand interactions [85] [5].
Integrin αIIbβ3 (the same as glycoprotein [GP] IIb-IIIa complex) is the most abundant
platelet surface membrane glycoprotein and its expression is specific to platelets and
megakaryocytes. This glycoprotein is essential for platelet aggregation, as this event is
mediated by the binding of fibrinogen or von Willebrand Factor (vWF) to integrin αIIbβ3
(see Figure 4.1). Integrin αIIbβ3 is a heterodimeric receptor that mediates platelet adhesion
and signaling by modulating their affinity and avidity for adhesive ligands; this process is
known as integrin activation or 'inside-out' signaling [5].
Platelet aggregation is a form of cell- to-cell adhesion that is mediated by the binding
of adhesive ligands to GPIIb-IIIa. Even though platelet activation and aggregation is
induced by a variety of stimuli, the aggregation response specifically requires the
presence of GPIIb-IIIa. Following that logic, GPIIb-IIIa receptor antagonists have been
used successfully in clinical trials as antithrombogenic agents [72] [86].
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GPIIb-IIIa plays a fundamental role in the process of thrombus formation, either
physiological (as a response to injury) or pathological (thrombosis).

Figure 4.1. Platelet aggregation mediated by the action of fibrinogen and von Willebrand
Factor (vWF) [87]

GPIIb-IIIa is expressed on the plasma membrane of the resting platelets, the
membranes of their α-granules and the open canalicular system as Ca2+-dependent
heterodimers. Additionally, it can bind to several macromolecular adhesive glycoproteins
(e.g., fibrinogen, vWF, fibronectin, and vitronectin, prothrombin and neural cell adhesion
molecule L1). Arginine-Glycine-Aspartic acid, known as RGD, is a sequence present in
the ligands that bind to GPIIb-IIIa, that serve as a recognition motif promoting cell-to-cell
and cell-to-matrix adhesion [88]. In resting platelets GPIIb-IIIa has a low activity for
ligand binding, but when platelets are exposed to a soluble antagonist (e.g. thrombin) or
subendothelial matrices, their ability to bind ligands increases rapidly. Stimuli engage
specific membrane receptors that induce cytoplasmic intracellular signals that activate
GPIIb-IIIa. The ligand necessary for platelet aggregation in vitro is fibrinogen [72] [5].
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4.2

The QCM Technology
The quartz crystal microbalance (QCM) is basically a mass sensing device with the

ability to measure very small mass changes on a quartz crystal resonator in real-time. The
sensitivity of the QCM is approximately 100 times higher than an electronic fine balance
with a sensitivity of 0.1 mg [89]. This means that QCM´s are capable of measuring mass
changes as small as a fraction of a monolayer or single layer of atoms [90].

Figure 4.2. Diagram of a quartz crystal sensor [91]

The high sensitivity and the real-time monitoring of mass changes on the sensor
crystal make QCM a very attractive technique for a large range of applications, including
its use under vacuum and, more recently its use with fluids or with viscoelastic deposits.
The QCM principle of operation is based on a piezoelectric quartz crystal sandwiched
between a pair of electrodes (see Figure 4.2) [90] [89]. When the electrodes are
connected to an oscillator and an AC voltage is applied over the electrodes, the quartz
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crystal starts to oscillate at its resonance frequency due to the piezoelectric effect. This
oscillation is generally very stable due to the high Q factor.
If a thin, non-dissipative layer is evenly deposited on the active electrode the resonant
frequency will decrease proportionally to the mass of the adsorbed layer according to the
Sauerbrey relationship [90], where Δf is linearly related to the adsorbed mass
𝛥𝑚 = 𝐶

𝛥𝑓

(Eq. 1.)

𝑛

where C is a constant based on the physical properties of the quartz crystal (𝐶 =
17.7

𝑛𝑔
𝑐𝑚 2 𝐻𝑧

at f=5MHz) and n is the overtone number (n=1,3,5,...).

If the damping of the deposited layers can be considered to be negligible, then the QCM
is used in order to study the dissipative processes on the quartz crystal. The Sauerbrey
relationship is not applicable for hydrated, highly viscous surface-adsorbed protein layers
that result in high dissipation shifts [90]. In those cases, in addition to measuring the
frequency, the dissipation is often measured to help with the analysis and the techinique
is called QCM-D, where the D stands for dissipation. The dissipation is a parameter
quantifying the damping in the system, and is related to the sample's viscoelastic
properties. Theorethical modeling of the response using dissipation requires the use of a
Voigt model, that characterizes the adsorbed layer using the following parameters:
effective density (ρ), shear viscosity (η), shear elastic modulus (µ) and thickness (δ) [90]
[72]. This method has been used mainly to study the interactions of proteins (including
blood serum proteins) with film coatings, especially polymeric coatings [88] [92] [93].
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4.3

Protein Adsorption Assessment Using QCM-D
Platelet aggregation is the primary mechanism of haemostatic control. It is widely

accepted that the hemocompatibility of a material is highly dependent of platelet
activation and aggregation onto its surface, which at the same time is dependent upon the
binding of fibrinogen to the surface of the material and of activated platelets which is
mainly mediated by platelet receptor GPIIb-IIIa [85]. Adsorption of plasma proteins to
materials influences the plasmatic (coagulation and complement) and cellular activation
pathways [72] [94].
These adhesive proteins, particularly fibrinogen, adsorb to surfaces within seconds of
contact. It has been reported in [95] that platelet adhesion to surfaces, in vitro, and
preadsorbed with plasma is mediated exclusively by fibrinogen and does not involve
other adhesion plasma proteins. Therefore a better insight into fibrinogen adsorption to
surfaces and platelet membrane receptor binding efficiency will provide a better
understanding of the hemocompatibility of a material.
QCM-D can monitor the formation of protein layers adsorbed onto the surface of a
quartz crystal in real time, by monitoring the resonant frequency shifts. In this study we
monitored the binding kinetics of purified GP IIb-IIIa to adsorbed fibrinogen using the
methods and protocols described in [72] and [96].
In order to assess the protein adsorption to 3C-SiC and compare it to Si, custom made
sensors were ordered from Q-Sense® [91]. We obtained four SiC coated sensors, four
gold (i.e., standard QCM-D surfaces), four silicon coated and four nanocrystalline
diamond (NCD) coated sensors. The gold sensors were used as sample controls, as it is
known that gold is used for blood contacting applications, and the NCD sensors to start
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exploring the hemocompatibility of this material due to the interest generated after Dr.
Frewin's research [11]. The main purpose was to compare fibrinogen and GPIIb-IIIa
adsorption to 3C-SiC vs. Si.
Protein-free TRIS buffer (Tris(hydroxymethyl)aminomethane) was prepared using
Trizma® HCL (cat. 1185-53-1), Trizma® Base (cat. 77-86-1) from Sigma®-Aldrich and
deionized water (with a resistivity of at least 16 MΩ·cm), to obtain a 50mM solution with
a 7.4 pH at 37°C. Divalent cations were added to the TRIS buffer as they are required for
GPIIb-IIIa binding to ligands [72] [5] [97] as follows: 100 mM NaCl (Sigma®-Aldrich,
cat. S5886-500G), 1 mM MgCl (Sigma®-Aldrich, cat. M8266-100G), 1 mM CaCl2
(Fisher, cat. S71924) and 1 mM MnCl2 (Fisher, cat. M87-500).
Human fibrinogen (cat. 341575) and human platelet receptor GPIIb-IIIa (cat. 528240)
were obtained from Calbiochem® and prepared to the following final working
concentrations: fibrinogen 50 µg/mL and GPIIb-IIIa 10 µg/mL.
Bovine serum albumin (BSA) was obtained from Fisher Scientific (Cat. BP671-10)
and prepared at a working concentration of 10% BSA (w/v). BSA was used to block
nonspecific GPIIb-IIIa binding to the surfaces.
Hydrogen peroxide (cat. 216763-100) and ammonium hydroxide (cat. 320145500ML) were obtained from Sigma®-Aldrich and used to clean the quartz crystal sensors
(Au, Si, SiC and NCD) following the protocol A-I from Q-Sense®. 2% (w/v) of sodium
dodecyl sulfate (SDS) from Sigma®-Aldrich (cat. L4390-100G) was prepared in DIwater in order to rinse extensively the Q-sense instrument chambers before and after
every experiment.
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Fibrinogen adsorption and the corresponding binding of the platelet receptor (GPIIbIIIa) to quartz crystals with a fundamental resonant frequency of 5 MHz coated with Si,
SiC and NCD was measured. Frequency shifts versus time curves, induced by sequential
adding of protein solutions (human fibrinogen, BSA, human GPIIb-IIIa), were recorded.
Each protein solution was incubated until the binding saturation was reached,
followed by a TRIS buffer rinse in order to remove non-bound proteins.
All experiments were repeated six times using the Q-Sense® E4 monitoring system at
37°C, in TRIS buffer under non-flow conditions and allowing the liquid in the QCM-D
chambers to exchange in every step via gravitational flow. 1.5 mL of solution per
chamber (TRIS, fibrinogen, BSA, GPIIb-IIIa) was loaded in every step and was sufficient
to fill the chambers and to allow for fluid exchange. All the solutions were degassed
before exposure to the chambers and crystal surfaces.
Frequency shifts induced by adsorbed proteins were monitored in real time at three,
five, and seven times the crystal’s natural frequency of 5 MHz. However, the data
provided by the first overtone had better stability, higher sensitivity and less glitch-like
errors, thus it was the one used for subsequent statistical analysis.
In order to obtain the baseline for the observed frequency shifts, 1.5 ml of degassed
TRIS was allowed to sit in each chamber. Once a constant baseline was obtained (and the
values compared to the acceptable values provided by Q-Sense®) the sensors were
exposed to the fibrinogen solution until saturation was reached, then it was followed by
TRIS rinsing and BSA incubation for 30 minutes. Next, the BSA was rinsed with a TRIS
buffer and the chambers filled with GPIIb-IIIa. The solution was allowed to sit until
saturation was reached. The chambers were rinsed thoroughly again using TRIS (see
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Figure 4.3). The measurements were stopped and the sensors and chamber cleaned using
SDS.

Figure 4.3. Sequence of steps of a typical hemocompatibility assesment using a Q-sense
device. TRIS buffer (50 mM TRIS, pH7.4 at 37°C containing 100 mM NaCl, 1 mM
MgCl2, 1 mM CaCl2 ).Fibrinogen concentration 50μg/ml, BSA 10%w/v, GPIIb-IIIa 10
μg/ml. Adapted from [96].

After every experiment the sensors were cleaned (Q-Sense®'s cleaning protocol A-I)
using an UV/Ozone chamber for 10 minutes, followed by dipping the sensor in a H2O2
(30%), NH4OH(25%), and DI-water solution in a 1:1:5 ratio for 5 min at 75°C. The
sensors were rinsed with DI-water, dried using nitrogen gas and stored in a desiccator, to
avoid surface changes due to contact with contaminated air.

4.4

Results
The custom made coated quartz sensors were created by sputtering the material of the

desired coating onto the surface of existing gold sensors. Unfortunately the NCD films
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peeled off from the gold surface after the cleaning and no measurements were obtained
for those films.
Additionally, after XRD, it was found that the SiC sensors did not correspond to 3CSiC (as it was requested) but to 4H-SiC. This unfortunate event did not allow the direct
comparison of 3C-SiC versus Si that was desired for this experiment.
Figure 4.4 shows a histogram of the frequency shifts due to the loading of fibrinogen
and GPIIb-IIIa for gold, silicon and 4H-SiC. From the statistical results (expressed as the
mean + standard deviation) it is evident that there is much more fibrinogen adsorption on
Si and 4H-SiC than on gold and the opposite is observed for GPIIb-IIIa.
In order to confirm these results ANOVA analysis (see Figure 4.5) and paired T-test
with Bonferroni adjustment were performed at a confidence level of 95% and it was
confirmed that the behavior of 4H-SiC was not statistically different from silicon. Gold
instead displayed significant differences from 4H-SiC and Si.
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Figure 4.4. Histogram of the fribrinogen and GPIIb-IIIa adsorption to gold, silicon and
4H-SiC substrates. Measurements made using a Q-Sense® E-4 QCM-D tool in the USF
FCoE BITT laboratory [98]
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ANOVA table for fibrinogen related frequency shifts

ANOVA Table for GPIIb-IIIa related frequency shifts

Figure 4.5. ANOVA tables of the statistical data for Fibrinogen (top) and GPIIb-IIIa
(bottom). Notice the low p value that indicates that statistical differences exist in at least
one pair of means.

Interestingly, 4H-SiC and Si presented high levels of Fibrinogen adsorption to their
surfaces. However, the percentage of GPIIb-IIIa that bound to the adsorbed fibrinogen
was less than the one that bound to gold.
The purpose of these experiments was to determine which material had higher degree
of protein adsorption. The substrates used were hard and non-viscous and the observed
dissipation values were negligible (the maximum value observed was 3.4 x 10-6 for
GPIIb-IIIa on gold,) and therefore Voigt models were not derived. Instead the mass
adsorption (expressed in ng/cm2) was derived using the Sauerbrey relationship (See
Figure 4.6).
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Figure 4.6. Histogram of the fribrinogen and GPIIb-IIIa mass (ng/cm2) adsorption to
gold, silicon and 4H-SiC substrates. Measurements made using a Q-Sense® E-4 QCM-D
tool in the USF FCoE BITT laboratory [98]
4.5

Discussion
From the previous platelet assessment experiment, we know that 4H-SiC performs

similarly to Si. These results were confirmed by the protein adsorption assessment using
QCM technology.
Unfortunately this experiment did not provide the desired information regarding
hemocompatibility of 3C-SiC.
Additionally, as more of the fibrinogen that adhered to gold mediated GPIIb-IIIa
binding, this result also implies a higher thrombogenic behavior of the gold surfaces used
in these experiments. Further experiments involving the interaction of platelets with these
protein layers, in order to determine if these values are directly correlated with higher
platelet aggregation to these surfaces in vitro, are required.
The small values for dissipation observed in these experiments contradict the results
reported in [99], where the dissipation was not negligible, and because the substrates for
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those experiments were polymeric films, that most likely were being hydrated as the
experiments were performed.
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Chapter. 5:

5.1

Microvascular Endothelial Cell Proliferation on Semiconductor Substrates

Microvascular Endothelial Cells and the Vessel Internal Lumen
Blood supply to the different tissues in the body depends on the blood vessels. The

internal lining of the blood vessels is composed of endothelial cells, the natural nonthrombogenic surface of the human body. If the continuity of the endothelial layer is
disrupted, this event initiates the activation of the clotting cascade. Endothelial cells form
the interface between the cells in the lumen and the vessel wall creating a flat pavementlike pattern that seals the vessel [100]. Endothelial cells are very flat, have a central
nucleus, are about 1-2 µm thick and some 10-20 µm in diameter [100], as shown in
Figure 5.1.

Figure 5.1. Fluorescent micrographs illustrating the pavement-like pattern of the
endothelial cells. Endothelial cells were stained using CMFDA cell tracker dye.

70

Endothelial cells are considered an adaptable life support system, extending cell
migration to almost every region of the body and adjusting their number and
configuration to adjust to local requirements [100]. This adjustable capability of the
endothelium, the thin single sheet of endothelial cells that lines the vessel wall, is
responsible for blood vessel remodeling, growth, angiogenesis (formation of new blood
vessels) and repair [100]. Endothelial cells act like selective filters which regulate the
passage of gases, fluids and various molecules across their cell membranes through the
action of their cell surface-molecule receptors and interaction sites that usually attract
leucocytes to the endothelium in the presence of inflammatory states.
Many leucocytes pass through endothelial cells, especially in capillaries as part of
their normal life cycle, so that they can monitor foreign agents (antigens) in the tissues.
Macrophages travel in the blood and pass through endothelial cells to gain access to
various tissues of the body [100] [101]. Endothelial cells also allow large amounts of
blood plasma fluids to pass through their intercellular junctions and create edemas as
response histamine released after tissue damage.
Another vital function of the endothelial cells is the synthesis of the Von Willebrand's
factor, essential for hemostasis [101].
Large blood vessels (i.e., arteries and veins) have a thick wall of connective tissue
and many layers of smooth muscle. The lumen of the large vessels is lined by the
endothelium, which is separated from the outer layer by a basal lamina, a layer of
extracellular matrix found on the basal surface of epithelial cells and secreted by them
(see Figure 5.2). The amounts of connective tissue and smooth muscle vary depending on
the vessel diameter, but the endothelium is always present. Capillaries are fine vessels
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that are only 10-15 µm in diameter and consist merely of endothelial cells and a very fine
layer of basal lamina. Apart from cartilage, every cell lies within a few µm of a capillary,
thus making endothelial cells vital for the integrity of almost every tissue of the body.

Figure 5.2. Diagram of a small artery in cross section. From [100].

Additionally, endothelial cells have mechanoreceptors that respond to shear stress due
to blood flow over their surfaces and, by signaling this information to the surrounding
cells, they enable the vessels to adapt their diameter and wall thickness to suit the blood
flow [100]. Endothelial cells also respond to neuronal signaling related to blood vessel
dilation by releasing NO gas, to make smooth muscle relax in the vessel [100]. The
former phenomena of vasoconstriction and vasodilation, mediated by the endothelial
cells, are the processes that regulate blood pressure [100].
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Endothelial cells reproduce by duplication of existing endothelial cells. If a part of the
vessel wall is damaged and denuded from endothelial cells, neighboring endothelial cells
proliferate and migrate to the exposed area [100]. Endothelial cells not only repair
existing vessels but also create new vessels (angiogenesis).
Endothelial cells line the entire vascular system, from the heart to the smallest
capillary, thus a material that is biocompatible with them and also displays low
thrombogenicity would provide an extra advantage for the development of cardiovascular
implantable applications (e.g., sensing devices and vascular grafts).

5.2

Cell Proliferation in Vitro: Experimental Protocol
Cells interacting with a biocompatible surface will increase their attachment area and

multiply, keeping their normal morphology, thus having greater viability than cells in
contact with cytotoxic surfaces [1] [37] [102] [74].
It has been proven that 3C-SiC has excellent biocompatible properties, however it has
also been shown in [11] that some cells prefer silicon, so in the particular case of
hemocompatibility of single crystal 3C-SiC versus silicon, it is necessary to evaluate cell
viability and morphology on the substrates of interest. In order to assess the
biocompatibility in vitro of 3C-SiC the methods outlined in the standard ISO 10993-1 [2]
were used including fluorescent microscopy and measurements of cell proliferation.
Cell proliferation was measured using yellow MTT (3-(4,5-Dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide, a tetrazole)) assays [9] [11] [103]. Yellow MTT
solution is reduced to purple formazan in the mitochondria of living cells. This reduction
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takes place only when mitochondrial reductase enzymes are active, and therefore
conversion can be directly related to the number of viable (living) cells [104] [105].
The absorbance of this colored solution can be quantified by measurement at a certain
wavelength (usually between 500 and 600 nm) by a spectrophotometer [103]. The higher
the cell proliferation the higher the amount of synthesized formazan and that translates to
an increased absorbance value. The MTT method of cell viability determination is most
useful when cultures are prepared in multiwell plates so that statistical analysis can be
performed to ensure that the data is significant.
The samples used in these experiments were low roughness single crystal 3C-SiC
films grown on Si(100) substrates and then diced into 8mm by 10 mm die. The samples
were selected from those of the platelet adhesion and morphology experiments described
in (§3.2) having flat surfaces with an average roughness of [0.25 + 0.11] nm, that was
estimated from AFM measurements taken in taping mode.
It has been reported that cell proliferation for cells seeded on samples that have been
repeatedly cleaned with piranha is reduced over time [106]. It is likely that repeated
piranha immersions may decrease the carbon concentration in the near surface region of
the SiC samples altering their surface wettability and biocompatibility. Piranha cleans of
a specific sample should be limited to a maximum of five as a precaution for cell
proliferation [106].
As the samples were used in several experiments that involved piranha cleaning, they
were hydrogen etched at 150 Torr pressure flowing 3 SLM of Pd (Palladium membrane)purified hydrogen, for 30 minutes at 1200 ºC. in a hot-wall CVD reactor specifically
designed for 3C-SiC growth and processing, which is described in [107] as the optimum
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method for 3C-SiC Hydrogen etching. 3C-SiC and Si die semiconductor samples where
cleaned following the protocol described in (§3.2) prior to any cell proliferation
experiment.
A normal human microvascular endothelial cell (HMVEC) line, cryopreserved from
adult dermis and capable of at least 16 population doublings, was obtained from
GIBCO® Invitrogen™ (Cat. C-011-5C) [108]. The cells were cultured in Corning®
Cellbind ® 75 mm2 culture flasks from Fisher scientific (Cat. 07-202-515) that were
coated with attachment factor (GIBCO® Invitrogen™ Cat. S-006-100) containing gelatin
at 0.1% [109]. The cells were grown using basal Medium 131 (GIBCO® Invitrogen™
Cat. M-131-500) supplemented with Microvascular Growth Supplement (MVGS)
(GIBCO® Invitrogen™ Cat. S-005-25) [109], containing fetal bovine serum (5% v/v
final concentration), hydrocortisone, recombinant human fibroblast growth factor,
heparin, recombinant human epidermal growth factor, and dibutyryl cyclic AMPand, and
1% penicillin-streptomycin. The cells cultures were incubated in a 37° C, 5% CO2/95%
air, and humidified cell culture incubator.
When the cultures reached 80%-90% confluence they were collected through
trypsination (using Trypsin/EDTA solution and Trypsin neutralizer), centrifuging at 180g
for 7 minutes and resuspending the cell pellet in supplemented Media 131. The density of
the cell suspension was later determined using a hemocytometer.
The cells were seeded then on BD Falcon™ primaria tissue culture 24-multiwell
plates (Fisher Cat. 08-772-4G), with flat bottom and enhanced reproductivity due to a
stable modification of the polystyrene surface that allows the proliferation of cell lines
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that grow poorly on standard tissue culture surfaces, and used as controls. Six wells were
pre-treated with attachment factor prior to cell seeding.
Six 3C-SiC/Si(100) die and six Si(100) die were used per experiment and each
experiment was repeated 3 times for each of the samples (i.e. three repetitions and 6
sample replicates per experiment). The samples were seeded with HMVEC after sample
cleaning and placement in an ultra-low attachment 24-multiwell plate from Corning®
(Fisher Cat. 07-200-602), in order to prevent cell migration and growth on the well
surface in case this was more biocompatible than the semiconductor samples. The area of
the wells used in these experiments was 200mm2. Figure 5.3 presents a schematic of the
sample positioning in the multiwell plates.

Figure 5.3 Schematic representation of sample position for cell plating experiments. Die
size 8mm x 10mm.
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The cells were seeded on the samples at a density of 15x103 cells/cm2 (determined
experimentally to avoid cell confluence before 168 hours), and the volumes of cell
suspension deposited on the samples scaled according to the respective plating areas (200
mm2 for the plates versus 80 mm2 for the semiconductor die), as described in [110],
followed with the addition of 2 ml of supplemented Medium 131, that was changed on a
daily basis.
After seeding, all the plated cells were incubated at 37 ºC for 72, 120 and 168 hours
in an air atmosphere containing 5% CO2 and 95% relative humidity. Next MTT assays
measurements were performed, using the BioTek Synergy 2 SLFA plate reader operating
at a wavelength of 540 nm, following the protocols in [34] [106] [103]. In order to reduce
sampling error in the absorbance measurement, 3 drawings of diluted formazan were
obtained per sample (replicates) and then averaged.
The measurements were normalized with respect to the average of the treated control
wells and expressed as sampling distribution of the mean (µ) ± standard error of the mean
(σ). The collected data was compared using ANOVA analysis and paired T-test with
Bonferroni adjustment, in order to determine significant differences between the samples
(treated wells, non-treated wells, 3C-SiC and Si) distributions.
The attached HMVEC were also stained using a fluorescent CellTracker™ probe
(Green CMFDA from Invitrogen, Cat. C2925) at a working concentration of 0.5 µM
[111]. This probe is retained in living cells, after passing freely through the cell
membrane and being transformed into cell-impermeant fluorescent dye. Living-cell
staining allowed for cell proliferation, morphology and adhesion quality assessment.
Fluorescence microscopy was performed using a Leica DM2000 compound microscope
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for the control wells and a Leica DM IL inverted microscope for the wafer die. The
results of the MTT assays and fluorescence microscopy are discussed in section (§5.3).

5.3

MTT Assay and Fluorescent Microscopy Results
Figure 5.4. displays the statistical analysis of the MTT readings after 72 hours. No

statistical differences were observed among the different substrates and this was
confirmed after ANOVA analysis, which yielded a large p value (p=0.598). This result
was consistent with the observed degree of cell proliferation on the different substrates,
obtained by fluorescence microscopy (see Figure 5.5). The adherent cells showed similar
morphology, and good adhesion indicating no preferential adhesion to any particular
substrate.
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Figure 5.4. (Top) Histogram displaying the normalized results (respect to the treated
wells) of the MTT assay after 72 hours. (Bottom) ANOVA table of the measured data.
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Figure 5.5. Fluorescent micrographs of HMVEC proliferation on various substrates
(treated well, non treated well, 3C-SiC and Si) after 72 hours.

Previous research on mammalian cell adhesion to SiC has shown that significant
differences in cell proliferation are typically observed after increasing the culturing time,
as long as confluence is not reached [106] [11]. Following the same rationale HMVEC
were cultured on the different substrates for longer times (i.e. 120 and 168 hours) in order
to determine if the cells had a different proliferation rate with time on any particular
substrate.
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Figure 5.6. (Top) Histogram displaying the normalized results (respect to the treated
wells) of the MTT assay after 120 hours. (Bottom) ANOVA table of the measured data.
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Figure 5.7. Fluorescent micrographs of HMVEC proliferation on various substrates
(treated well, non treated well, 3C-SiC and Si) after 120 hours.

Figures 5.6 and 5.7 show the statistical analysis of the MTT assays and the
fluorescent micrographs for adherent cells after 120 hours of seeding. In this case a
higher proliferation was observed on silicon and the result was statistically confirmed by
the paired test. The wells treated with attachment factor, the non-treated well and 3C-SiC
substrates had no statistical differences for the cell viability measurement, however Si
displayed an increased proliferation that was statically different from all the other
samples. After well treatment it was expected to have an increased proliferation on these
wells than on the non-treated wells. However as the culture insert used for the controls
have a high reproductive nature it actually does not make any difference to use the
attachment factor. This is completely different from culturing the cells in conventional
culture flasks were, if attachment factor is not used, only a small percentage of the cell
suspension is attached to flask culture surface.
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Figure 5.8. (Top) Histogram displaying the normalized results (respect to the treated
wells) of the MTT assay after 168 hours. (Bottom) ANOVA table of the measured data.

Non-Treated Well

3C-SiC/Si(100)

Si(100)

20x

Treated Well

Figure 5.9. Fluorescent micrographs of HMVEC proliferation on various substrates
(treated well, non treated well, 3C-SiC and Si) after 168 hours.

The same trend was observed again after 168 hours (see Figures 5.8 and 5.9). A
higher cell proliferation was observed on Si, which was as high as 60% more than the
proliferation observed for the other cultures, and statistically different from the other
substrates (which display no statistical differences among them).
No morphological differences were observed among the substrates. Healthy elongated
endothelial cells proliferate on the substrates creating mosaic-like patterns that had good
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quality of adhesion (flattened cells) and no morphological changes as the culturing time
increased.
3C-SiC displayed consistently good biocompatibility that was statistically comparable
to high proliferation culture wells. In [11] it was reported that certain cell lines can induce
physical damage on the substrate surfaces. The Si and 3C-SiC surface morphology were
evaluated before and after culturing (after cleaning) and no differences were observed in
surface morphology before and after cell seeding and removal.

5.4

Discussion
After the excellent platelet adhesion and morphology assessment results that were

obtained for 3C-SiC, it was very compelling to evaluate its compatibility with the cells
that line the cardiovascular system (endothelial cells). An adult human dermis
microvascular cell line was selected and cell proliferation was evaluated on 3C-SiC and
Si, the leading material for biomedical sensing applications.
After statistical analysis of the MTT assays and morphological evaluation of cell
cultures it was found that 3C-SiC had an excellent biocompatibility with this cell line,
comparable with the culture inserts treated with attachment factor or equivalent high
reproductivity culture wells. However Si displayed a superb proliferation, about 60%
above the culture wells and 3C-SiC, without affecting cell morphology (cell were
flattened, elongated and well spread on the surface), which means that this high
proliferation was not the result of cell mutation or accelerated proliferation, but rather the
effect of enhanced cell and cell adhesion protein attachment.
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These results may induce us to think of Si as a superior material with biocompatible
characteristics, which for the case of HMVEC appears to be true, but it does not
necessarily mean that the material is more hemocompatible. When interpreting these
results one must think of the final application, which in this case is the future
development of cardiovascular devices. If Si is coated with a lining of endothelial cells,
and implanted in the human body, it is likely that its surface is denuded from cells at
some point, exposing a highly thrombogenic surface to the blood stream, activating
therefore the clotting cascade and presenting an elevated risk or material debris
contaminating the blood stream due to Si's lack of mechanical resilience.
On the other hand, the reason why Si outperformed 3C-SiC is most likely related to
the high attachment of adhesion proteins to its surface due to the effect of its
hydrophobicity and protein layer-film interfacial tension [84] [112] [113], especially Von
Willebrand's Factor, which is produced constitutively by the endothelium and is present
in the blood plasma [100]. It has been reported in [114] that substrates coated with Von
Willebrand's Factor have higher platelet adhesion and aggregation as this factor is
responsible for platelet tethering and translocation. Therefore it must be considered that
protein adhesion adsorption onto surfaces requires a compromise, in this particular case
the same reason that enhances cell proliferation on Si substrates is the same reason that
makes it perform poorly when in contact with plasma proteins and platelets.
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Chapter. 6:
6.1

Conclusions and Future Work

Conclusions: 3C-SiC Versus Si
To date, few crystalline semiconductor materials have been assessed for their

biocompatibility. Crystalline semiconductor materials are of special interest for the
development of biomedical sensors that can be in intimate contact with the human body.
Therefore biocompatible sensing materials are critical to the development of implantable
biomedical devices and this dissertation was dedicated to evaluating the biocompatibility
of such materials for use in the cardiovascular system.
The development of implantable sensors that are placed in the blood stream has faced
many challenges dominated by the hemocompatibility of the materials that can be used
for their fabrication. The formation of thrombus on the surface of the semiconductors is
of special concern and is a response to the activation of the clotting cascade, and the
subsequent embolization of the thrombus. Many polymeric coatings have been developed
or modified in order to reduce the thrombogenicity of engineered materials, but these
coatings have all degraded over time once they are placed in the human body and thus
make long-term cardiovascular implants very difficult to achieve
The former states the necessity of a semiconductor material that is biocompatible,
hemocompatible and chemically and mechanically resilient, as the material needs to be in
contact with the harsh environment of the body (i.e., bodily fluids).
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Two materials were selected for this research in order to compare their
hemocompatibility, namely Si and 3C-SiC. Silicon is a material traditionally used for the
development of MEMS devices, and is the main semiconductor used for biomedical
applications and is known to be biocompatible with certain cell lines.
3C-SiC is a chemically and mechanically resilient wide band-gap semiconductor,
very suitable for harsh environments, that has been proven to be biocompatible with
several cell lines, but whose hemocompatibility in the single crystalline state has not yet
been reported.
To the best of our knowledge this is the first research that directly compares
crystalline Si and 3C-SiC for their hemocompatibility. In order to assess the
hemocompatibility of these semiconductor materials, three different aspects involved in
thrombosis were used to design the experiments (see §2.3): 1) the platelet adhesion and
morphology assessment, 2) the protein adsorption perspective and 3) the human
microvascular endothelial cell proliferation perspective.
Platelet adhesion and morphology were assessed after the exposure of platelet-richplasma (PRP) to different SiC polytypes, two different crystal orientations and as a
function of surface roughness, and the results were contrasted to those of Si(100) wafer
die (§3.2). In each case single crystal 3C-SiC grown on Si(100) substrates had the best
performance, with low particle adhesion counts and small-area adhered platelets that also
showed high platelet circularity. Si, 4H-SiC and 6H-SiC displayed high thrombogenicity
and were therefore determined to be non-suitable for cardiovascular applications
A second experiment was designed (§4.3) to monitor protein adsorption onto the
surface of 3C-SiC, nano-crystalline diamond (NCD) and Si coated quartz crystal sensors
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using QCM-D technology. Unfortunately the NCD coatings peeled off and the SiC sensor
coating was 4H-SiC instead of 3C-SiC. However from this experiment it could be
confirmed that protein adsorption to Si and 4H-SiC are statistically similar, which
confirms the platelet adhesion and morphology results observed on those substrates
during the first experiment reported here (§3.2) It was also found that the viscosity of the
protein layers adsorbed to the hard substrates was smaller than for the proteins adsorbed
onto polymeric film coatings.
Next, proliferation of human microvascular endothelial cells (HMVEC) on 3C-SiC
substrates was directly compared to Si substrates (§5.2). Cell viability was quantified
using MTT assays (§5.3) and cell morphology inspected using fluorescence microscopy
(§5.4).
After statistical analysis of the MTT assays and morphological evaluation of cell
cultures it was found that 3C-SiC had an excellent biocompatibility with this cell line,
comparable with the culture inserts treated with attachment factor or equivalent high
reproductivity culture wells. However, Si displayed higher proliferation than 3C-SiC and
appears to be more biocompatible with HMVEC.
Cells proliferate on both substrates without altered cell morphology, which is a good
indication of non-degenerative interactions at the cell-material interface (good
biocompatibility) [115].
It was concluded that even though Si has a higher biocompatibility for microvascular
endothelial cells, this does not necessarily imply hemocompatibility, as the cell
proliferation was assessed in vitro and in the absence of blood interactions. If a material
that displays high thrombogenicity also displays good HMVEC compatibility, one must
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consider the implications of this material being coated with endothelial cells and then
being placed in the blood stream. Under those conditions, if the material is denuded from
endothelial cells, then the platelet attachment and activation response will be faster than
the cell's capability to cover the surface [116], therefore the thrombogenic nature of the
base material (as indicated by platelet adhesion assessment) will negate the positive
endothelial cell biocompatibility result and makes Si non-suitable for cardiovascular
applications in the long term.
The reason why Si outperformed 3C-SiC in cell proliferation assessment is most
likely related to the high attachment of adhesion proteins to its surface. Therefore a
proper balance of the amount and type of proteins adsorbed to surfaces is required to
guarantee hemocompatibility.
3C-SiC demonstrated in vitro characteristics that are highly desirable for
cardiovascular applications including low thrombogenicity and good compatibility with
endothelial cells. 3C-SiC has a better trade off, between cell proliferation and platelet
adhesion, in vitro than silicon.
The low thrombogenicity of 3C-SiC reduces the chances of catastrophic failure of a
device due to thrombi embolization and its resilience reduces the chances of material
debris falling into the blood stream.

6.2

Future Work
The experiments performed in this research provided insight into the compatibility of

3C-SiC and silicon with blood. However in order to develop implantable sensing devices
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and two aspects should be explored more on detail: the behavior of the material in vivo
and the interaction of the material with plasma proteins.
However, in order to address hemocompatibility in vivo, hemocompatibility must be
first studied under blood flow conditions.
Additionally, the study of surface-protein interactions is key to truly understanding
the mechanisms behind the hemocompatibility of a material and to functionalize surfaces.
Surface functionalization is perhaps the most challenging and the last step required to
develop an implantable sensing device.
The enzyme-linked immunosorbent assay, also called ELISA, is a technique used to
detect the presence of an antibody or an antigen in a sample. This technique can be used
in vitro in order to detect and quantize platelet activation by measuring the levels of
relevant platelet metabolic products [117] (e.g. alpha granule components such as beta
thromboglobulin and Platelet Factor 4) that are specific to platelet release or the presence
of the soluble form of the adhesion molecule P-selectin [118] after contact with the
semiconductor material surfaces.
Raised levels of soluble P-selectin are found in a variety of thrombotic disorders and
its levels do not seem to be influenced by the various anticoagulants and different
methods of plasma preparation [68] [119] making it an ideal candidate for further
evaluation of the thrombogenicity of blood contacting materials. These types of
measurements will provide additional information regarding platelet activation in the
presence of material-blood plasma interactions.
In order to detect activated platelets under flow conditions the surface expression of
P-selectin can be performed using fluorescence-activated flow cytometry [120]. This
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technique would also involve the detection of antigens on the membrane of activated
platelets (e.g., GP IIb-IIIa), platelet surface bound fibrinogen and it would additionally
allow the detection platelet changes in shape of activated circulating platelets in contact
with the materials [121].
Future work regarding the coating of quartz crystal sensors with 3C-SiC single crystal
films would allow the study of fibrinogen and GPIIb-IIIa onto this substrate using QCMD. If this were possible, the QCM-D experiment could be extended to the exposure of
flowing platelets to the layer of pre-adsorbed proteins, and quantize the degree of platelet
adhesion and activation related to protein adsorption. Following the same rationale, 3CSiC could be compared to sensors coated with hemocompatible polymeric films.
Finally, an important step in the development of an implantable sensor would be the
study of plasma protein adsorption and platelet activation related to the semiconductor
surface energy.
Perhaps the most useful step in the determination of the hemocompatibility of any
material would be in vivo biocompatibility studies whereby the material is implanted into
the blood stream of a living animal and analyzed following the appropriate amount of
time. However this last step is very time consuming and expensive and should only be
considered once the previous suggested future work research steps have been completed
successfully.
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